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Apoptosis is a process by which unwanted cells are eliminated in a controlled 
manner. Early in apoptosis, ceramide levels rise and the mitochondrial outer membrane 
becomes permeable to proteins. The permeability of the outer membrane is attributed to 
the self-assembly of ceramide in form of channels. In the only direct structural study, to 
date, ceramide channels were visualized in liposomes using transmission electron 
microscopy. Those channels were of various sizes, averaging 10 nm in diameter. In 
concert, using electrophysiological techniques, the estimated diameter of ceramide 
channels was also around 10 nm. These channels are large enough to release all the pro-
apoptotic intermembrane space proteins to initiate apoptosis. 
Dihydroceramide desaturase converts the inactive precursor, dihydroceramide to 
ceramide. Both long and short chain dihydroceramides inhibit ceramide channel 
formation in mitochondria. The inhibition is strong as one tenth as much 
dihydroceramide inhibited the outer membrane permeabilization by 95% (C2) and 51% 
(C16). Other mitochondrial components are not required for such inhibition as comparable 
amounts prevented the permeabilization of liposomes. Hence, the apoptogenic activity of 
ceramide may depend on the ceramide to dihydroceramide ratio perhaps resulting in a 
more abrupt transition from the normal to the apoptotic state. 
The location of the desaturase is the endoplasmic reticulum (ER). Only minimal 
activity was measured in mitochondria. However, newly synthesized ceramide from 14C-
C8-dihydroceramide or 3H-sphingosine (in the ER) can transfer rapidly to mitochondria 
(40 % in 10 min) and permeabilize them to cytochrome c and adenylate kinase. The 
transfer of sphingolipids is bidirectional and non-specific. The transfer mechanism is 
consistent with direct membrane contact, since reducing the organellar concentrations by 
half resulted in a four-fold reduction of the transfer rate.  Thus this ceramide exchange 
obviates the need for a complete ceramide de novo pathway in mitochondria in order for 
cells to use ceramide to activate mitochondria-mediated apoptosis. 
These results demonstrate the ability of ceramide to form large channels capable 
of releasing proteins from mitochondria.  Ceramide can rapidly reach mitochondria and 
there are mechanisms to control the propensity for ceramide channel formation.  Clearly 
ceramide channels play a central role in the decision to undergo apoptosis.   
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 This is my thesis in which I present a synopsis of my research on the metabolism 
and transport of a vital lipid molecule, ceramide. I joined Dr. Marco Colombini’s lab at 
the University of Maryland, College Park about 4 years ago and I embarked on studying 
ceramide channel activities in planar phospholipid membranes. For about two years, I 
have tried to find molecules that either enhance or destabilize ceramide’s ability to form 
channels in a completely biophysical study. I discovered that trehalose and, to a lesser 
extent, sucrose were able to disrupt channel formation and they might be possible 
inhibitors of this process.  I also developed a method to measure the channel formation 
activity in unilamellar liposomes. Using this method, and in collaboration with Prolexys, 
a chemical company in Salt Lake City, Utah, we are planning to scan a variety of 
compounds to see their effects on channel formation. This could potentially help future 
studies on apoptosis. 
 
 Although I did enjoy the electrophysiological studies, I wanted to go back to my 
original passion, biochemistry. Following an excellent advice from Dr. Jeffery Davis, I 
tested the ability of the inactive precursor, dihydroceramide, to influence the channel 
formation activity of ceramide. Amazingly, not only did dihydroceramide prove to be 
inactive, but inhibitory as well. I showed that in liposomes and in isolated mitochondria, 
dihydroceramide is able to significantly inhibit ceramide channel formation. This was 
presented in my first paper (Stiban et al., 2006). 
 
 After the first paper, I realized that it is important to localize the enzyme that is 
responsible for the conversion of dihydroceramide to ceramide, dihydroceramide 
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desaturase. Studies have shown that this enzyme is a resident of the endoplasmic 
reticulum. I wanted to test whether it is also found in mitochondria. Indeed, I was not 
able to find significant enzyme activity there. However, when both substrates of this 
enzyme were mixed with mitochondria, permeabilization of the outer membrane to 
cytochrome c occurred, similar to the effects of adding ceramide. This was surprising. 
Nevertheless, I found that ceramide and dihydroceramide added to ER membranes 
transport rapidly to mitochondria. In vivo, this is important because of the close proximity 
of these two membranes. This work was summarized in my second first-author paper 
submitted for publication in Biochimica et Biophysica Acta – Biomombranes. 
 
 I also tried to develop a technique to visualize those channels in liposomes by 
electron microscopy. I wanted to use Osmium tetroxide as a fixative agent that adds to 
double bonds (in ceramide) and stains them. I started the work but then I focused on my 
previous projects. In the meantime, Ms. Sarah O’Connell continued the EM work and 
was able to get a formula that worked well. After Ms. O’Connell left the lab, I took over 
and finished the project of visualizing these interesting structures. This work will be 
submitted soon. 
  
 I have six chapters in this dissertation. In the first chapter, I introduce the general 
background of apoptosis; the sphingolipid ceramide and its metabolism. In chapter two, I 
detail the methods used to obtain my results. Chapters three, four and five are distinct 
manuscripts that summarize my research experience in Dr. Colombini’s lab. In chapter 
three, I address the issue of dihydroceramide inhibition of ceramide channels. The next 
chapter characterizes the metabolism and transport of ceramide between neighboring 
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membranes; and chapter five introduces the imaging of ceramide channels. In the final 
chapter, I summarize and discuss my results shedding some light on future research 
directions. 
    
 After the good experience and unconditional support from Dr. Colombini who 
never ceased to amaze me not only with scientific prowess but with his creativity and 
craftsmanship, I am glad that my work has finally come to fruition.  
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CHAPTER 1  
GENERAL INTRODUCTION 
Programmed Cell Death (Apoptosis) 
Programmed cell death, or apoptosis, is the mechanism by which cells repackage 
and feed themselves to neighboring cells when they receive death signals. There are two 
pathways that trigger apoptosis, extrinsic and intrinsic. Apoptosis can be initiated from 
signals coming from outside the cell, for instance, a killer lymphocyte which has Fas 
ligand will bind to Fas receptors on the target cell. This generates a set of intracellular 
signal transduction events involving the activation of caspase-8 that eventually leads to 
the repackaging of the cell. In addition, the removal of growth factors induces DNA 
damage, mitochondrial permeabilization and ultimately apoptosis. Alternatively, the 
signal can originate within the cell. The permeablization of the mitochondrial outer 
membrane releases cytochrome c and other intermembrane space proteins to the cytosol. 
Such a release causes a series of events involving the activation of caspase-9 and the 
initiation of the caspase cascade that leads to the death of the cell. Consequently, solute 
and protein efflux from the intermembrane space of mitochondria is significant for 
apoptosis. Even though there are various pathways proposed for this release, this 
dissertation will focus on the evidence for a ceramide-based large mitochondrial outer 
membrane channel. 
Originally, morphological analysis was used to determine whether the cell is 
dying from apoptosis or from necrosis. Necrotic cells release proteins and osmolytes to 
the environment. This causes inflammatory reactions (Kerr et al., 1972). During 
apoptosis, such reactions do not take place (Gulbins et al., 2000). The modern 
characterization of apoptosis can be summarized as follows: The chromatin of an 
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apoptotic cell condenses, the nucleus fragments and phosphatidylserine flips from the 
inner to the outer leaflet of the bilayer (Jacobson et al., 1993; Jacobson et al., 1994). The 
cell loses its attachment to other cells (Wyllie et al., 1980; Ruoslahti and Reed, 1994), the 
plasma membrane becomes disorganized and blebbed and the cell shrinks (Jacobson et 
al., 1993; Jacobson et al., 1994).  Metabolic energy is needed to synchronize and 
coordinate these events. The apoptotic cell is transformed into membrane-bound entities 
called the apoptotic bodies (Kerr et al., 1972), which are identified and endocytosed by 
phagocytes (Hart et al., 1996) avoiding any inflammation that would be caused by the 
release of certain proteins and metabolites to the environment. 
 
Causes of Apoptosis 
 
As aforementioned, various factors are known to affect the initiation of apoptosis. 
DNA damage, for instance, induces apoptosis. Stress and disruption of calcium 
homeostasis also cause programmed cell death. The inhibition of metabolite exchange 
between the cytosol and mitochondria, by VDAC (voltage-dependent anion channel) 
closure as a result of treatment with phosphorothioate nucleotides is also linked to 
inducing apoptosis (Lai et al., 2006; Tan et al., 2006). Cell proliferation and cell death 
are tightly regulated by the cell cycle enzymes as well as by Bcl-2 family proteins, NAIP 
(neuronal apoptosis inhibitor protein), TNF (tumor necrosis factor), etc. The mechanisms 
by which each protein is involved in preventing or inducing apoptosis are diverse and not 
very well characterized; however, it seems that the interactions of such proteins with 
mitochondria lead to the release of mitochondrial intermembrane space proteins such as, 
among others, cytochrome c, SMAC/Diablo and apoptosis-inducing factor (AIF).  
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Once cytochrome c is released from the intermembrane space into the cytosol, it 
can bind to the apoptotic protease-activating factor 1 (APAF-1). The immediate effect of 
this binding is the activation of caspase-9 by cleaving procaspase-9. Caspase-9 then 
cleaves and hence activates caspase-3, which is the main effector of the caspase cascade 
in the intrinsic pathway (Liu et al., 1996; Yang et al., 1997). Through the caspase cascade 
events, other enzymes, such as endonucleases, transglutaminases and DNases get 
activated and start degrading the cell, each within its capacity. Moreover, other caspases 
are activated by the cascade and these are important in activating other cytosolic proteins 
that eventually facilitate the blebbing of the plasma membrane and the rest of the 
morphological changes associated with apoptosis. Even though studies have showed that 
the cell that is committed to die has to pass through the irreversible step of cytochrome c 
release from mitochondria (Susin et al., 2000), cells must have a functional APAF-1 in 
order to die when cytochrome c is released (Sanchis et al., 2003). Fig. 1.1 demonstrates 












The Release of Pro-apoptotic Proteins 
The execution phase of intrinsic apoptosis begins with the egress of 
intermembrane space proteins into the cytosol. The mechanism by which mitochondria 
release cytochrome c and other pro-apoptotic proteins is still under investigation and a 
variety of processes have been proposed.  This thesis investigated the hypothesis that 
ceramide-based water-filled pathways, or channels, in the mitochondrial outer membrane 
mediate the release of intermembrane space proteins and initiate apoptosis. 
An aqueous pathway through the membrane is both necessary and sufficient to 
allow the release of cytochrome c from mitochondria.  Even though cytochrome c is a 
component of the mitochondrial electron transport chain, it is not an integral part of an 
 
 
FIG. 1.1. General apoptosis pathways (information reproduced and modified from Parone 
et al., 2002). 
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enzyme complex residing in the mitochondrial inner membrane. Due to its solubility, it 
transports electrons from the ubiquinone:cytochrome c oxidoreductase (complex III) to 
cytochrome oxidase (complex IV), which reduces molecular oxygen to water (Tyler, 
1992; Nelson and Cox, 2000). Cytochrome c is confined between the mitochondrial outer 
and inner membranes (the intermembrane lumen). Mostly, it is soluble but some is 
attached to the outer surface of the inner membrane (Tyler, 1992; Nelson and Cox, 2000). 
As a highly charged (+7) small (13 kDa) globular protein, cytochrome c should not be 
able to cross membranes spontaneously.  The two pathways across the outer membrane, 
VDAC and TOM, are either too small or too highly regulated to allow cytochrome c 
release. The mechanism by which cytochrome c leaks out of the mitochondrial 
intermembrane space is still unclear. Nevertheless, there are many theories in the field 
today to explain this phenomenon. 
A variety of mechanisms have been proposed for the release of cytochrome c 
(reviewed in Siskind, 2005):  the opening of the permeability transition pore (PTP) 
(Crompton, 1999), the forming of lipidic pores induced by Bax (Basaňez et al., 1999), the 
oligomerization of Bax monomers to achieve channel activity (Antonsson et al., 2000, 
2001; Saito et al., 2000), the opening of the mitochondrial apoptosis-induced channels 
(MAC) (Pavlov et al., 2001), the interactions of BH3/Bax/cardiolipin (Kuwana et al., 
2002), the interactions between Bax and ceramide (Lee et al., 2002; Belaud-Rotureau et 
al., 2000; Pastorino et al., 1999), and ceramide channels (Siskind and Colombini, 2000; 
Siskind et al., 2002; 2003). There are many conflicting reports that the PTP complex 
includes VDAC, cyclophilin D and ANT (adenine nucleotide translocator), yet knockout 
experiments using mice lacking these proteins are also capable of undergoing apoptosis 
(Krauskopf et al., 2006; Kokoszka et al., 2004; Halestrap, 2004; Forte and Bernardi, 
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2005). Hence, the PTP is not a well characterized channel as it was once thought to be. 
Moreover, cardiolipin is a molecule known to destabilize membranes; therefore any 
induction of apoptosis by its action on mitochondria can be simply by disintegrating the 
outer membrane in a detergent-like manner. Furthermore, MAC channels were reported 
to be involved in later stages of apoptosis rather than initiating the process (Guihard et 
al., 2004) thus cannot be the pathway for protein release to start the execution phase.  
No direct structural evidence for any of the aforementioned pathways has been 
presented thus far. However, results presented in this thesis (detailed in chapter 5) show 
the structure of ceramide channels, negatively stained in liposomes. The size of these 
channels is consistent with a pore that allows large (around 115 kDa) proteins to pass 
through. Hence, to date, ceramide channels provide the only ultrastructural 
characterization for a pore capable of initiating apoptosis. 
 
Ceramide  
More than a century ago, in 1884, German physician-biochemist Johann 
Thudichum discovered a class of lipids whose properties were so enigmatic that he 
named them sphingolipids, after the mysterious Sphinx (Thudichum, 1884). When they 
were discovered, the role of sphingolipids was not understood, hence the name. 
Nonetheless, in this past decade, sphingolipid research has prospered and many roles 
have been assigned to these molecules.  
There are many members of the sphingolipid family. The main sphingolipid, 
ceramide, (Fig. 1.2) is a molecule involved in intracellular signaling.  C16-ceramide, or N-
palmitoyl-D-erythro-sphingosine, is one of the forms of naturally occurring ceramides.  
Ceramides differ in their fatty acid groups. They can have either long or short tails. 
 
 
Naturally occurring ceramides have long tails. In this thesis, short-chained C2-ceramide, 
or N-acetyl-D-erythro-sphingosine, medium-chained C8-ceramide, or N-octanoyl-D-
erythro-sphingosine, and long-chained C16-ceramide, or N-palmitoyl-D-erythro-
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transferase (SPT). This enzyme is a heterodimer (53 and 63 kDa 
 
 8
subunits) that is bound to the ER membrane (Hanada, 2003). The product (3-
ketosphinganine) is later reduced by the NAD(P)H ketosphinganine reductase in a rapid 
reaction resulting in sphinganine. Dihydroceramide synthase (an ER enzyme) acylates 
sphinganine into dihydroceramide (Lahiri and Futerman, 2005).  The latter is desaturated 







FIG. 1.3. The de novo ceramide synthesis pathway. 
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Another way of producing ceramide in the cell uses sphingomylinase (SMase) to 
hydrolyze sphingomyelin (Fig. 1.4). There are five different isoforms of SMase. Three of 
them are acidic (requiring an acid environment to function) and the other two are neutral 
(Marchesini and Hannun, 2004). Neutral sphingomyelinases are cloned and localized to 
the endoplasmic reticulum (ER), Golgi apparatus or plasma membrane (Clarke et al., 
2006). The localization of ceramide metabolism enzymes has been shown to be primarily 
in the ER and Golgi even though some reports find some enzyme isoforms in 









Although mitochondrial ceramide machinery might be less efficient than that in 
the ER, ceramide levels increase in mitochondria prior to apoptosis. Thus, the trafficking 
of ceramide from its production site to its functional site is important. The intercellular 
trafficking of ceramide is discussed in details in chapter 4.  
 
Lipid Transport 
 In the cell, lipids have to move from one compartment to another. Most of the 
cell’s lipids are made in the ER (Bishop and Bell, 1988) before being transported to the 
 
FIG. 1.4.  Sphingomyelin hydrolysis pathway.
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Golgi complex where they are sorted and distributed to various destinations. There are 
three main mechanisms of lipid movement. First, lipids can be transported via vesicular 
trafficking. Vesicles containing the desired lipid form from the donor membrane, with the 
help of necessary proteins, then they bud off and move to the acceptor membrane where 
they dock and fuse releasing the lipid in that membrane. Second, since lipids are 
hydrophobic, they can be transported through the aqueous environment of the cell using 
protein shuttles. A cytosolic, soluble protein extracts the needed lipid molecule from the 
donor membrane and transports it to the acceptor membrane. The third mechanism of 
lipid trafficking occurs by direct membrane contact. Some lipids can flip from one 
membrane to a neighboring membrane quickly. Because of the close proximity of the ER 
to mitochondria, a unique system of interorganellar lipid transport system is found for the 
transport of some phospholipids.   
 The close apposition between ER and mitochondria allows for membrane contact 
and lipid exchange. For instance, even though most of the enzymes responsible for 
phospholipid synthesis are found in the ER, mitochondria also carry some enzymes such 
as phosphatidylserine decarboxylase (Dennis and Kennedy, 1972). This enzyme catalyzes 
the reaction of decarboxylating phosphatidylserine (PS) to make 
phosphatidylethanolamine (PE) (Dennis and Kennedy, 1972; Voelker, 1989; Vance, 
1991).  In order to make PE, PS (formed in the ER) needs to rapidly move to 
mitochondria, get decarboxylated and move back to the ER as PE (Vance, 1990; Vance, 
1991; Shiao et al., 1995; Gaigg et al., 1995; Vance and Shiao, 1996).  The transport of PS 
and PE to and from the ER and mitochondria provides the evidence of membrane contact 
trafficking (Daum and Vance, 1997; Voelker, 2005) rather than vesicular transport 
(Voelker, 1989; Vance et al., 1991).  
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 Whereas the import of phospholipids from the ER into mitochondria has been 
studied in details (reviewed in Daum and Vance, 1997) the exchange of sphingolipids 
between these two organelles has not. Sphingolipids use vesicular trafficking to move 
from ER to Golgi (van Meer and Lisman, 2002; Futerman and Riezman, 2005). The 
movement of sphingolipids between ER and mitochondria has yet to be investigated 
thoroughly, although some mechanisms were proposed (Futerman, 2006).  As mentioned 




 Once formed in the mitochondria, ceramide channels induce the execution phase 
of apoptosis. The addition of ceramide to whole cell cultures induces the release of 
cytochrome c (Zamzami et al., 1995; Castedo et al., 1996; Susin et al., 1997; De Maria et 
al., 1997). It also stimulates the release in isolated mitochondria (Arora et al., 1997; Di 
Paola et al., 2000; Ghafourifar et al., 1999). The permeability of the mitochondrial outer 
membrane to proteins can be enhanced by the incubation with ceramide in a dose- and 
time-dependent fashion (Siskind et al., 2002). Previous experiments showed the 
molecular weight cutoff of ceramide channels to be 60 kDa (Siskind et al., 2002). This 
molecular weight cutoff of the ceramide channel is large enough to allow the passage 
cytochrome c and other small pro-apoptotic intermembrane space proteins during 
apoptosis. In chapter 5, the cutoff size for protein release from mitochondria (using a 
different vehicle) was measured to be higher (around 115 kDa), indicating the delivery of 
ceramide can be important for its ability to permeabilize the outer membrane of 
mitochondria. Ceramide channels (Fig. 1.5) are proposed to form from columns 
 
 
composed of six ceramide molecules.  Many columns, arranged in an anti-parallel 
fashion, self-assemble to form cylindrical channels of varying diameters. The insertions 
of more columns increase the diameter of the channel. The lumen of the channel is 
bounded by an ice-lattice like structure of hydrogen bonding between the ceramide 
hydroxyls. 
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Even though ceramide was shown to form channels in the mitochondrial outer 
membrane and in planar phospholipid membranes (Fig. 1.6), it does not form channels in 
every type of membranes. Ceramide does not induce the permeabilization of the inner 
membrane of the mitochondria as there were no detectable traces of fumerase activity 
(Siskind et al., 2002). Moreover, studies on red blood cells showed that the addition of 
ceramide results in no channel formation in this plasma membrane (Siskind et al., 2006). 
The specificity of channel formation by ceramide could be due to differences in the lipid 




















 Apoptosis is a factor in a wide variety of diseases. Cancer, for example, occurs 
when cells grow uncontrollably and continue to proliferate. These cells can become 
resistant to chemotherapy or radiation therapy because their apoptotic mechanism is 
suppressed.   Following an ischemic episode, reperfusion often results in widespread 
inappropriate apoptosis. This often occurs in heart attacks and strokes. Characterizing and 
 
FIG. 1.6.  Ceramide channel activity in planar membranes. Ceramide was 
added at time = 0 seconds.
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outlining the initiation mechanism of apoptosis is essential in order to design drugs that 
might kill infected cells or inhibit killing of necessary cells. This approach may help in 
the treatment of common diseases such as cancer, stroke, heart disease, 
neurodegenerative diseases, autoimmune disorders, and viral diseases such as AIDS. 
 In the past few years, our lab has shown that ceramide is able to form organized 
channels in a variety of membrane systems. This unique ability of ceramide to self-
assemble and permeabilize membranes, especially mitochondrial outer membrane, in an 
ordered fashion is believed to be critical for the initiation of the process of apoptosis. 
Hence, depending on the metabolic levels of ceramides in the cell, the cell can stay viable 
or undergo apoptosis. 
 Controlling ceramide channel formation in vivo may help the shift from cell 
viability to cell death, or vice versa. If, for example, one can prevent channel formation in 
cardiac cells following a heart attack, those cells may not undergo apoptosis and therefore 
be able to rescue the patient. On the other hand, if one can figure out ways to stabilize 
these channels (or enhance ceramide production in mitochondria), cancerous cells can be 
killed. In vivo, results presented in chapter 3 indicate that the ratio of ceramide to 
dihydroceramide may be a toggle switch between cells with permeabilized mitochondria 
(cells destined to die) and cells with intact mitochondrial outer membrane. The 
dihydroceramide inhibition of ceramide function is remarkable because it gives insight 
into a natural process of selecting for cell death or cell viability. Indeed, other molecules, 
whether physiological or drugs, must be tested for their ability to stabilize or destabilize 






 A method was developed to measure channel formation in liposomes. This assay 
uses the dequenching of the fluorophore carboxyfluorescein as it leaves the liposomes as 
a means of detecting its release. The liposomes (Fig. 2.1) are made so that they contain 
carboxyfluorescein (CF) and quencher p-xylene-bis-pyridinium bromide (DPX). When 
these molecules are entrapped in vesicles, the fluorescence signal is small (because of the 
quenching). When the liposomes are permeabilized, these molecules are quickly released, 









A soybean polar lipid extract, asolectin, was used because its lipid composition is 
close to that of the outer membrane of mitochondria. Basically, 2.9 mg asolectin and 0.1 
mg cholesterol are mixed together in chloroform. This mixture is then dried under 
nitrogen to obtain a thin layer of lipids on the wall of the container. Afterwards, the lipids 
DPX
CF A liposome
This drawing was modified from 
http://avantilipids.com/liposomes.asp  
FIG. 2.1. A depiction of a liposome entrapping CF and DPX molecules.
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are desiccated overnight under house vacuum. The next morning, the lipids are hydrated 
in 1 mL of CDL Buffer (1.5 mM CF, 6 mM DPX, 50 mM NaCl, 10 mM HEPES, 1 mM 
EDTA pH 7.0). After vortexing the mixture and forming the liposomes, 4 freeze-thaw-
sonication steps are performed to thoroughly disperse the lipids. In order to obtain 
uniform single walled liposomes that are approximately 0.2 µm in diameter, the vesicles 
are extruded through a 0.2 µm-polycarbonate membrane. To remove the un-trapped 
fluorescent molecules, gel filtration is used (Sephacryl S-200).   
The liposomes are ready to be used after being eluted from the column. The 
liposomes (100 µL) are diluted into 2 mL of L medium (50 mM NaCl, 10 mM HEPES, 1 
mM EDTA pH 7.0). The fluorescence is measured in a spectrofluorometer set at the 
necessary wavelengths (for CF, the excitation wavelength is 495 nm and the emission 
wavelength is 520 nm). The liposomes are stable and for at least 2 days, however, most 
of the experiments are done on the day the liposomes were formed. Fluorescence is 
measured as a function of time. Ceramide, in different combinations, (please see chapter 
3 for details) is added and the fluorescence increase is recorded. In order to assess the 
total fluorescence in that batch of liposomes, towards the end of the experiment, 150 µL 
of 5% Triton-X 100 is added to release the CF from all the liposomes.  This allows the 
results to be expressed as a percentage of the fluorescence released by adding ceramide. 
 
Isolation of Rat Liver Organelles 
Mitochondria are isolated from male Sprague-Dawley rat liver as described by 
Parsons et al. (1966) as modified by Siskind et al. (2002) and Stiban et al. (2006). 
Briefly, a rat (200 to 300 g) is fasted overnight, anesthetized using CO2 and decapitated. 
Immediately the liver is removed, rinsed and chopped in ice-cold HB-isolation buffer 
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containing 210 mM Mannitol, 70 mM sucrose, 10 mM HEPES, 0.1 mM EGTA and 0.05 
mg/mL of fatty acid-free Bovine Serum Albumin, pH 7.4. Small pieces of the cut liver 
are homogenized in HB-buffer using a motorized Teflon-glass Potter homogenizer. The 
homogenized tissue is then centrifuged at 760 ×g for 10 minutes at 4 oC in order to pellet 
cell debris and nuclei. The supernatant, consisting of mitochondria, microsomes and 
peroxisomes, among other things, is collected and re-spun for 10 minutes at 9000 ×g so 
that mitochondria can pellet, leaving the microsomes (including ER vesicles) in the 
supernatant. Multiple low and high-speed steps were used to purify the mitochondria 
prior to resuspending the mitochondrial pellet in HB lacking BSA. In all the resuspension 
steps, cut pipette tips were used to prevent sheering of mitochondria and to increase the 
degree of intactness. 
The protein content of these isolated mitochondria can be measured using a 
method that takes advantage of the differential absorbance of proteins and DNA.  Using 
this rapid spectroscopic method (Clarke, 1976), a 20-fold dilution of stock mitochondria 
in H-buffer is followed by a 2-fold dilution in 100mM Tris.SO4, 0.4% SDS, pH 8.0 
solution. The absorbance at 2 wavelengths (280 nm and 310 nm) is measured and the 
concentration of protein (in mg/mL) is given by:
05.1
40 )Α−Α(× 310280 . 
ER membranes are separated following the modified procedure of Schulze et al. 
(1999). The supernatant from the first 9000 ×g spin is centrifuged at 105,000 ×g for 1 
hour at 4oC. The pellet is washed 3 times prior to resuspension in H-buffer. Another 9000 
×g spin is performed for 10 minutes in order to separate some attached mitochondria in 
the pellet. The supernatant (ER vesicles) is collected and the protein concentration is 
determined using the BCA protein assay kit from Pierce (Rockford, IL). 
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In order to purify the mitochondria further (mainly from the mitochondria-
associated ER membrane, or MAM), isolated mitochondria are layered on a 28% self-
generating Percoll gradient following the procedure of Holden and Colombini (1993). 
The Percoll-layered mitochondria are then centrifuged at 39,000 ×gmax for 30 minutes 
collecting the mitochondrial fraction near the bottom of the tube. The collected fraction is 
diluted in H-buffer and spun at 9000 ×g for 10 minutes to remove the Percoll.  
 
Isolation of Rat Erythrocytes 
Mammalian red blood cells (erythrocytes) are a model system for the plasma 
membrane. They lack intracellular organelles, and and thus are essentially sacks of 
hemoglobin. In order to isolate erythrocytes, blood from a decapitated rat is collected in a 
tube pre-filled with an anticoagulation buffer (AB) containing 150 mM NaCl, 4 mM 
EGTA and 5 mM HEPES, pH 7.4. Red blood cells easily sediment by centrifugation, 
therefore, the blood sample is spun at 600 ×g for 10 minutes, these cells were collected in 
the pellet. The cells are washed and resuspended in AB and pelleted 3 times. After the 
third spin, the hemoglobin was released from the cells by osmotic shock (in double 
distilled water). The membranes of these lysed cells are collected as the pellet of a 12,000 
×g spin for 10 minutes. After every spin, the membranes were resuspended in double 
distilled water to effectively wash out hemoglobin. This step is repeated 3 times. Finally, 
the membranes are resuspended in AB and their protein content is measured by the BCA 
assay.  
 
Cytochrome Oxidase Accessibility Assays 
The permeability of the mitochondrial outer membrane to cytochrome c was 
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measured using the method of Siskind et al. (2002). Reduced cytochrome c is made by 
reducing it with ascorbic acid (5.5 mg cytochrome c with 2 mg ascorbic acid in 250 µL of 
150 mM NaCl, 10 mM HEPES, 1 mM EDTA, pH 7.2). The reduced cytochrome c is then 
separated from the ascorbic acid by running the sample on a gel filtration column. When 
added to mitochondria the oxidation rate can be a determined by recording the 
absorbance at 550 nm.  This oxidation rate is a measure of the permeability of the outer 
membrane to cytochrome c.  
 
Planar Membrane Technique 
Ceramide channels were first discovered (Siskind and Colombini, 2000) using the 
planar membrane technique (Montal and Mueller, 1972; Schein et al., 1976; Colombini, 
1987). I have used this technique sparingly to look at inhibitors and enhancers of 
ceramide channels and to measure of the size of the channel. The apparatus consists of a 
Teflon chamber with two compartments (cis and trans) divided by a Saran partition with 
a 100 µm hole.  
Various lipids can be used to generate these membranes.  The lipids used in my 
research were either 5:5:1 diphytanoylphosphatidylcholine (DPhPC), asolectin (soybean 
phospholipids polar extract), cholesterol (w/w/w) or 10:1 DPhPC, cholesterol. Lipid 
monolayers are used to form a bilayer membrane (Fig. 2.2). The current is measured as 
the voltage across the membrane is clamped (Fig. 2.3). The membrane should not be 
conductive as monitored by the current recorded as positive and negative voltages are 
applied. The aqueous solution normally contained 100 mM KCl, 1 mM MgCl2, 5 mM 
PIPES (pH 7.0). All the experiments were performed at room temperature (about 23oC). 
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The side that is kept at ground (normally the far side) is defined as trans and the 
front side is the cis-side. The voltage is controlled in the cis-side. Ceramide was added to 
both sides, typically 25 µL of 0.1 mg/mL or 2.5 µL of 1 mg/mL. The ceramide solution 













Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE)  
Blue Native (BN)-PAGE is a technique used to separate proteins on a gel based 
on their size but under native conditions (Schägger and von Jagow, 1991; Schägger et al., 
1994). It involves incorporating a negatively-charged dye, Coomassie Brilliant Blue G-
250 (Fig. 2.4) into the cathode buffer. This dye coats all the proteins in the sample and 
gives them a total negative charge. The extent of binding of the dye is proportional to the 
size of the protein, hence, the farther the protein migrates on the gel, the smaller it is. The 
binding of the dye to the proteins typically does not denature them, unlike SDS-PAGE, 










FIG. 2.3. The experimental set-up used for planar membrane measurements. 
A Teflon partition divides the chamber into two compartments. The lipid bilayer 
is formed across the hole of 100 µm diameter. The ion flux across the membrane 
is recorded as a current and the voltage (V) is controlled by a pair of potassium 
chloride electrodes connected to the ground and amplifier (►), respectively. The 
amplifier is set in the voltage clamp mode with feedback resistor Rf. 
 
 
gradient polyacrylamide gel is used. In my experiments, I used 4-16% polyacrylamide 
pre-made gels from Invitrogen. Following the manufacturers’ instructions, the cathode 
buffer contains 50 mM BisTris, 50 mM Tricine and 0.02% Coomassie G-250, pH 6.8. 
The anode buffer consists of the same ingredients without the dye. Also, a 4× sample 
buffer is made. That consists of 50 mM BisTris, 50 mM NaCl, 10% glycerol and 0.001% 
bromophenol blue, pH 7.2. 
The protein sample is mixed with the 4× sample buffer in a 3:1 volume ratio and 
then loaded on the gel. The electrophoresis was run for 2 hours at room temperature at 
150 V. After the run is complete, the gel is destained in 40% CH3OH, 10% CH3COOH at 
first then overnight in 8% CH3COOH. After the destaining, the bands are stained but 











In this chapter, 
well as methods 
 
 
FIG. 2.4. Coomassie Brilliant Blue G-250 molecule. 22
ods were used and they are detailed in each chapter, where appropriate. 
I described, in details,  methods that were essential for my research as 
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 Early in apoptosis, ceramide levels rise and the mitochondrial outer membrane 
becomes permeable to small proteins. The self-assembly of ceramide to form channels 
could be the means by which intermembrane space proteins are released to induce 
apoptosis.  Dihydroceramide desaturase converts dihydroceramide to ceramide.  This 
conversion may be removing an inhibitor as well as generating a pro-apoptotic agent.  
We report that both long and short chain dihydroceramides inhibit ceramide channel 
formation in mitochondria.  One tenth as much dihydroceramide was sufficient to inhibit 
the permeabilization of the outer membrane by about 95% (C2) and 51% (C16).  Similar 
quantities inhibited the release of carboxyfluorescein from liposomes indicating that other 
mitochondrial components are not necessary for the inhibition. The apoptogenic activity 
of ceramide may thus depend on the ceramide to dihydroceramide ratio resulting in a 
more abrupt transition from the normal to the apoptotic state when the de novo pathway 






Ceramides are sphingosine-based lipids that normally exist in cell membranes at a 
steady state level.  This level is increased in cells undergoing apoptosis (for review, see 
Hannun, 1996; Kolesnick and Fuks, 2003; Reynolds et al., 2004) and this increase is 
thought to be an important step in the apoptotic process.  
Ceramide’s role in apoptosis is quite extensive and diverse.  It has been proposed 
that ceramide induces apoptosis via several routes. For instance, by clustering into 
ceramide-enriched domains in the plasma membrane, ceramide is able to recruit or 
cluster Fas receptors to induce Fas-mediated apoptosis (Grassme et al., 2001A; Grassme 
et al., 2001B; Cremesti et al., 2001; Miyaji et al., 2005). Ceramide is also believed to be 
involved in reorganizing small membrane rafts into signaling platforms in response to 
stress. The control seems to arise from ceramide locally generated within rafts (for 
review, see Gulbins and Kolesnick, 2003). Ceramide administration changed the 
phosphorylation states of some MAP kinases (Willaime et al., 2001; Kitatani et al., 2001; 
Shin et al., 2002; Willaime-Morawek et al., 2003; Stoica et al., 2005) and since this 
coincides with the release of cytochrome c, AIF, SMAC, and Omi from mitochondria this 
change in phosphorylation state is believed to be causal (Stoica et al., 2005). In 
differentiating embryonic stem cells, ceramide is reported to mediate the binding of 
protein kinase C zeta (PKCζ) to its inhibitor PAR-4 (prostate apoptosis response-4) and 
this is proposed to be responsible for the induction of apoptosis in these cells (Wang et 
al., 2005). 
Ceramide could also initiate apoptosis by permeabilizing the mitochondrial outer 
membrane to pro-apoptotic proteins found in the intermembrane space.  The release of 
these proteins into the cytosol has been shown to be a critical step in committing a cell to 
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irreversible apoptosis.  This permeabilization can be performed by ceramide directly 
because both short chain (C2) and long chain (C16) ceramides form channels in planar 
phospholipid membranes (Siskind and Colombini, 2000) and in liposomes (this study). 
The addition of ceramide to whole cell cultures induces the release of cytochrome c into 
the cytosol (Zamzami et al., 1995; Castedo et al., 1996; Susin et al., 1997; De Maria et 
al., 1997). Ceramide also induces the release of cytochrome c in isolated mitochondria 
(Arora et al., 1997; Ghafourifar et al., 1999; Di Paola et al., 2000). The permeability of 
the mitochondrial outer membrane to proteins can be enhanced in a dose- and time-
dependent fashion by incubation with ceramide (Siskind et al., 2002). This permeability 
showed a molecular weight cutoff of 60 kDa (Siskind et al., 2002). This is an appropriate 
size for releasing the known pro-apoptotic proteins from the mitochondrial 
intermembrane space.  
Dihydroceramide is almost identical to ceramide except that it lacks a critical 
trans double bond at the 4, 5 position.  It is an intermediate in the de novo synthesis 
pathway and is believed to be biologically inactive in that it cannot cause cells to undergo 
apoptosis (Bielawska et al., 1993; Sugiki et al., 2000) nor can it induce the release of 
cytochrome c when added to isolated mitochondria (Siskind et al., 2002) or cell cultures. 
Dihydroceramide also does not form channels in planar phospholipid membranes 
(Siskind and Colombini, 2000) or in liposomes (this study).  However, rather than simply 
being inactive, we provide evidence that it can be inhibitory. Indeed we find that both C2- 
and C16-dihydroceramide interfere with ceramide channel formation both in mitochondria 
and in liposomes. Generation of ceramide by the de novo pathway involves converting 
dihydroceramide to ceramide.  Our results indicate that both the process of depleting 
dihydroceramide and augmenting ceramide levels are important in the generation of 
 
 27
ceramide channels and the induction of apoptosis.  This combined effect would sharpen 





MATERIALS AND METHODS 
Materials - Asolectin (polar extract of soybean lipids), C2-ceramide, C2-dihydroceramide, 
C16-ceramide and C16-dihydroceramide were supplied by Avanti Polar Lipids (Alabaster, 
AL). Analytical-grade DMSO (from Fisher) was used to dissolve C2-ceramide and C2-
dihydroceramide whereas isopropanol (from Acros Organics) was used to dissolve C16-
ceramide and C16-dihydroceramide. 4-Carboxyfluorescein (CF) and p-xylene-bis-
pyridinium bromide (DPX) were obtained from Molecular Probes (Eugene, OR).  
Cytochrome c and bovine serum albumin (BSA, fatty acid depleted) and cholesterol were 
from Sigma (St. Louis, MO). Sodium ascorbate was bought from Acros Organics. 
 
Mitochondria - Mitochondria were isolated from male Sprague-Dawley rat liver as 
described by Parsons et al. (1966) as modified (Siskind et al., 2002). In brief, young rats 
(generally 200 to 300 g), fasted overnight with water ad labitum, were decapitated, the 
liver excised and cut in ice-cold isolation buffer (210 mM Mannitol, 70 mM sucrose, 1 
mM TRIS, 100 µM EGTA and 0.05 mg/mL of fatty acid-free Bovine Serum Albumin, 
pH 7.4; i.e. HB-buffer). The liver was minced and homogenized in a motorized Potter 
homogenizer with loose Teflon pestle (two passes).  The homogenate was centrifuged at 
760 ×g for 10 minutes at 4 oC. The supernatant was then spun for 10 minutes at 9000 ×g 
to recover mitochondria. This sequence was repeated but the second high-speed spin was 
performed without BSA (H-buffer).  Finally the mitochondrial pellet was resuspended in 
the isolation buffer without BSA. 
The protein concentration of the mitochondrial suspension was measured by using 
a spectroscopic method (Clarke, 1976). In short, 25 µL of the suspension was diluted in 
475 µL of H-buffer without BSA. Five hundred µL of 100 mM Tris:H2SO4, 0.4% SDS 
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pH 8.0 was added to the mitochondrial suspension and the absorbance measured at 280 
nm and 310 nm. The protein concentration is
05.1
40 )Α−Α(× 310280 . Reduced cytochrome c 
was prepared by mixing 11 mg of cytochrome c with 4 mg sodium ascorbate in 0.5 mL of 
buffer Q (200 mM HEPES, 10 mM EGTA, pH 7.5). The reduced cytochrome c was 
separated from the ascorbate on a Sephadex G-10 gel filtration column pre-equilibrated 
with buffer Q. 
The mitochondria (50 µL of 0.2 mg/mL) were suspended in 0.75 mL of isotonic 
H-medium supplemented with 2.2 µM antimycin A and 2 mM 2,4-dinitrophenol and 
treated with ceramide or dihydroceramide in different doses. The permeabilization of the 
mitochondria was measured by monitoring the reduction of the absorbance of added 
reduced cytochrome c at 550 nm. C2-ceramide and dihydroceramide were added as 10 µL 
of a DMSO solution.  The dose of ceramide therein was kept the same (2.5 µL of 4 
mg/mL or a total of 29 nmoles) and it was mixed with various amounts of 
dihydroceramide and DMSO to achieve the concentrations of DHC2 used in each 
experiment. C16-ceramide and dihydroceramide were added as 50 µL of an isopropanol 
solution.  It contained a constant 25 µL of 2 mg/mL C16-ceramide (93 nmoles) diluted 
with 25 µL of either isopropanol or DHC16 in isopropanol (1 mg/mL) to achieve the 
desired amount of dihydroceramide.  Vehicle controls were performed as appropriate. 
 
Liposomes - Liposomes were made after mixing the lipids (93% asolectin and 7% 
cholesterol, by weight) in chloroform and the solvent was evaporated under nitrogen and 
overnight in vacuum. The lipids (total of 5 mg) were hydrated in a buffer containing 1.5 
mM CF 6 mM DPX 38.8 mM NaCl 10 mM HEPES and 1mM EDTA pH 7.0. The 
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liposomes were vortexed and subjected to 4 cycles of freeze-thaw-sonication followed by 
freeze-thawing and extrusion through a polycarbonate membrane to form uniform single 
walled vesicles (100 nm). A Sephacryl S200 gel filtration column (1.5 cm×30 cm) was 
used to separate the liposomes from unloaded fluorophore. 100 µL of the liposome 
suspension (containing approximately 0.1 mg of lipid) were diluted into 2 mL of 50 mM 
NaCl, 10 mM HEPES, 1 mM EDTA pH 7. The liposomes were assessed for their 
fluorescence in a Deltascan spectrofluorometer (Photon Technology Instruments). CF 
was excited at 495 nm and the emitted light detected at 520 nm. The fluorescence was 
measured as a function of time and then different concentrations of C2-ceramide, C16-
ceramide or C2-ceramide premixed with DHC2 were added. The increase in fluorescence 
was the result of the release of CF from the liposomes and its dilution from the quenching 
agent, DPX.  The maximal increase in fluorescence was measured following the addition 






Ceramide permeabilizes mitochondria and dihydroceramide blocks this 
permeabilization 
The permeabilization of the outer membrane of isolated rat liver mitochondria 
was achieved by measuring the oxidation of exogenously added cytochrome c by 
mitochondria. Cytochrome oxidase carries electrons from cytochrome c to molecular 
oxygen, thus oxidizing cytochrome c. If the outer membrane is intact, cytochrome c will 
not be able to cross it to get to the cytochrome oxidase. Permeabilization of the outer 
membrane to cytochrome c can be detected by the oxidation of cytochrome c measured as 






FIG. 3.1. Cytochrome oxidase accessibility assay. Measuring MOM 
permeabiliy. A permeabilized outer membrane allows for the rapid oxidation of 
exogenously added reduced (+2) cytochrome c using the inner membrane 
integral enzyme, cytochrome oxidase. 
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 Incubation of mitochondria with 29 nmoles of C2- (Fig. 3.2a) or 93 nmoles of C16-
ceramide (Fig. 3.2b) for 10 minutes induced a permeability to cytochrome c as evident by 
the fast decrease of the level of reduced cytochrome c.  Alternatively, incubating 
mitochondria with a similar dose of C2- or C16-dihydroceramide (DHC2 or DHC16) 
caused no permeabilization of the mitochondria. The slow decrease in the reduced 
cytochrome c after dihydroceramide occurred at the same rate as untreated mitochondria 
or mitochondria treated with DMSO (results not shown; see also Siskind et al., 2002). 
When dihydroceramide is premixed with ceramide, the ability of ceramide to 
permeabilize mitochondria was effectively reduced (Fig. 3.2a and b) and this reduction 






The amounts of C2- and C16-ceramides used were chosen to produce close to 
maximal effects, hence increasing the signal to noise ratio. These amounts were higher 
than the physiological levels of ceramide in mitochondria (about 52 pmol C2 per nmol 
 
FIG. 3.2. Dihydroceramide inhibits the permeabilization of the mitochondrial 
outer membrane by ceramide.  The percent of cytochrome c in the reduced state 
is plotted as a function of time after the addition of 29 nmol C2-ceramide, 29 
nmol dihydroceramide (DHC2) and 22 nmol DHC2 + 29 nmol C2 (panel a), 93 
nmol C16, 46 nmol DHC16 and 46 nmol DHC16 + 93 nmol C16 (panel b) to 0.75 
mL of mitochondrial suspension (13 µg of mitochondrial protein per mL). 
 
 
mitochondrial phospholipid and 168 pmol C16 per nmol mitochondrial phospholipid♦) 
However, under physiological conditions, C2-ceramide channel formation (Fig. 3.3a 
inset) was inhibited by DHC2 and C16-ceramide was also inhibited by DHC16 (data not 
shown). Moreover, the estimated physiological levels of ceramide needed to initiate 
apoptosis are average levels, whereas the local concentration of ceramide (produced by 
dihydroceramide desaturase) must be much higher. Thus the reported influence of 
dihydroceramide on channel formation should be physiologically relevant. 





FIG. 3.3. Dihydroceramide reduces ceramide channel formation in mitochondria. 
(a) The initial rate of oxidation of cytochrome c, obtained from experiments 
similar to those shown in Fig. 1, is shown as a function of the amount of DHC2
added to a fixed amount of C2-ceramide (as indicated).  The points collected at 29 
nmoles of DHC2 had no added C2-ceramide.  The results were collected in three 
different experiments. The amount of mitochondria used in the experiments 13 
µg/mL.  The baseline oxidation rate (DMSO alone) was subtracted from each 
point. Inset: Low levels of ceramide and dihydroceramide were used along with a 
higher mitochondrial protein concentration (133 µg/mL).  (b) A bar graph showing 
similar results for the effects of DHC16 on C16-ceramide channel formation.  Again 
the results were obtained from 3 independent experiments, hence the large error 
bars. “Lysed” refers to the rate of cytochrome c oxidation after hypotonic shock 
(20 µL of mitochondria were diluted to 1.5 mL with water).  The results represent 
the mean of three experiments ± S.D. The level of statistical significance from 





                                                   
e calculation is based on the percent insertion of added ceramide into the mitochondrial membranes 
ind et al., 2005). For 40 µM C2, about 2 percent inserts in the membranes. In mitochondria, total 
holipid in the membranes is about 680 µg phospholipid per mg protein (Tyler, 1992).  
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Mitochondria were incubated with each of the mixtures for 10 minutes and the 
reaction was started by the addition of reduced cytochrome c. Pre-incubation with 
ceramide alone induced the greatest permeabilization. Premixing ceramide with 
dihydroceramide greatly reduced the ceramide-induced permeabilization. The effect was 
dose-dependent and even a small ratio of dihydroceramide to ceramide reduced the 
ability of ceramide to permeabilize the outer membrane. This indicates that 
dihydroceramide is able to block the formation of ceramide channels in mitochondria. 
 
 
Liposomes are permeabilized by ceramide in a dose-dependent manner 
The release of trapped carboxyfluorescein (CF) from liposomes was monitored by 
an increase in fluorescence. The addition of ceramide to liposomes preloaded with CF 
and the quencher p-xylene-bis-pyridinium bromide (DPX) leads to an increase in 
fluorescence.  Permeabilization of the liposomes allows the efflux and dilution of the CF 
and the quencher resulting in an increase in fluorescence (Fig. 3.4a). The maximal 
possible increase was obtained by the addition of the detergent, Triton-X100.   
The amount of CF released depends on the amount of ceramide added.  The larger 
the amount of C2- (Fig. 3.4b) or C16-ceramide (Fig. 3.4c) that was added, the greater was 
the rate of fluorescence increase and thus the greater the chance for channels to form and 
release CF. Considering the small size of the liposomes and the large size of the ceramide 
channels (Siskind and Colombini, 2002; Siskind et al., 2002), once a channel is formed 
the liposome should rapidly equilibrate its content with the medium.  Thus the rate of 
fluorescence increase reflects the rate of channel formation in liposomes.   
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The greater apparent potency of C2 as compared to C16 is probably due to the 
problem of delivering ceramide to the liposome membrane.  A smaller fraction of C16-
ceramide partitions into the membrane as compared to C2-ceramide (Siskind et al., 2005).  
Both DHC2 and DHC16 did not cause permeabilization when added to liposomes 
even at concentrations 10 times higher than the respective ceramides (data not shown). 
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Dihydroceramide inhibits ceramide channel formation in liposomes 
To test whether mitochondrial proteins might be required to mediate the 
dihydroceramide inhibition of ceramide channel formation, liposome studies were 
undertaken.  Using the same technique described above, fluorescence increases were 
monitored following the addition of C2-ceramide (Fig. 3.5a, open symbols) or C2-
ceramide premixed with DHC2 (closed symbols).  The presence of DHC2 reduced the 
fluorescence increase induced by C2-ceramide addition.  Thus the inclusion of 
dihydroceramide with ceramide effectively reduced ceramide channel formation in a 
dose-dependent fashion (Fig. 3.5b).    
FIG. 3.5. Dihydroceramide inhibition of ceramide-induced release of CF from 
liposomes. (a) The premixing of dihydroceramide with ceramide (closed symbols) 
greatly reduced the release of CF from liposomes observed with ceramide alone (open 
symbols).  The average traces of 3 independent experiments are shown. (b)
Dihydroceramide inhibited the ceramide-induced permeabilization in liposomes in a 
dose-dependent manner. The fluorescence increase following the addition of 30 nmol 
ceramide mixed with the values of DHC2 shown was normalized by that induced by 
30 nmol ceramide alone. The results represent the mean of 3 independent experiments 
± S.D. The statistical significance between 2 adjacent points is determined with *, P ≤ 
0.05 and **, P ≤ 0.01.  38
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The sequence of addition of ceramide and dihydroceramide is important for the 
inhibition 
When mitochondria were pretreated with 15 nmoles of ceramide alone to form 
ceramide channels and then exposed to 15 nmoles of dihydroceramide, the latter did not 
reduce the rate of oxidation of exogenous cytochrome c. Therefore, during the time 
allowed, dihydroceramide was not able to disassemble the channel once it was formed 
(Fig. 3.6a). However pre-incubation of mitochondria with 15 nmoles of dihydroceramide 
for the indicated times followed by addition of 15 nmoles of ceramide did inhibit 
ceramide channel formation (Fig. 3.6a). This indicates that dihydroceramide interferes 
with the initiation or nucleation of ceramide channels rather than disassembling them. 
Figure 3.6b shows that premixing 29 nmoles of ceramide and 22 nmoles of 
dihydroceramide and adding them together to the liposomes inhibits the release of CF, 
whereas if they are added simultaneously but separately there is almost no effect. This is 
consistent with the notion that sparingly soluble lipophilic molecules form aggregates 
that are fairly stable (Gruy et al., 2005). Adding ceramide premixed with 
dihydroceramide leads to aggregates containing both molecules. When these aggregates 
fuse with liposomes, the propensity of ceramide to form channels is undermined by the 
presence of dihydroceramide. When ceramide and dihydroceramide are added at the same 
time but using separate pipettes, the tendency of forming mixed aggregates is now much 
less and the aggregates of ceramide that fuse with membranes can form channels.  The 
path dependence of the observations clearly demonstrates the relatively slow rates of 
interaction between these components.  It also rules out the possibility that 
dihydroceramide micelles might interfere with channel formation by adsorbing ceramide 
molecules and thus depleting the available ceramide. Indeed pre-incubating liposomes 
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with dihydroceramide for up to 5 minutes prior to ceramide addition did not change the 
rate of ceramide channel formation (data not shown).  The dihydroceramide micelles are 
there but ceramide channels form anyway.  These results indicate that the 
dihydroceramide inhibition phenomenon is probably not due to its ability to form 
micelles that might interfere non-specifically but rather due to direct interference with 
ceramide nucleation and channel formation.  
 
  
FIG. 3.6. Dihydroceramide inhibits the formation of ceramide channels and does not 
induce channel disassembly. (a) The initial rate of cytochrome c oxidation by 
mitochondria following various treatments: hypotonic shock (lysed); 15 nmol C2 for 15 
min. (C2); 15 nmol DHC2 for 15 min. (DHC2); preincubation with 15 nmoles C2 for 10 
min followed by 15 nmoles DHC2 for 5 min (C2 then DHC2); preincubation with 15 
nmoles DHC2 for the indicated time followed by 15 nmoles C2 for the remainder of 15 
min (DHC2 then C2). (b) The premixing of 29 nmol C2 with 22 nmol DHC2 reduced the 
permeabilization of liposomes by ceramide. However, the addition of 29 nmol C2 and 29 
nmol DHC2 separately but simultaneously (together) had almost no effect compared to the 




 Apoptosis occurs normally via two distinct pathways, extrinsic and intrinsic. 
Apoptosis can be initiated from signals coming from outside the cell or, alternatively, the 
signal can originate within the cell. The permeablization of the mitochondrial outer 
membrane is believed to be the first committed step in apoptosis since cytochrome c and 
other intermembrane space proteins are released into the cytosol. The starting phase of 
the intrinsic pathway of apoptosis is well characterized; however, the cause of the 
permeability of the outer membrane is still debated. The mechanism by which 
mitochondria release cytochrome c is still under investigation and a variety of processes 
have been proposed (Siskind, 2005). In our model, ceramide-based water-filled pathways, 
or channels, in the mitochondrial outer membrane mediate the release of intermembrane 
space proteins and initiate apoptosis (Siskind et al., 2002; Siskind et al., 2003).  
An aqueous pathway through the membrane is both necessary and sufficient to 
allow the release of cytochrome c from mitochondria. Cytochrome c is confined between 
the mitochondrial outer and inner membranes (the intermembrane lumen). Some is in 
solution and the rest is attached to the outer surface of the inner membrane (Tyler, 1992; 
Nelson and Cox, 2000). As a highly charged (+7) small (13 kDa) globular protein, 
cytochrome c is not able to cross membranes spontaneously.  The two pathways across 
the outer membrane, VDAC and TOM, are either too small or too highly regulated to 
facilitate the translocation of cytochrome c. Ceramides (both long chain and short chain) 
have been shown to form large stable channels in planar membranes (Siskind et al., 
2003). C16-ceramide (and other similar synthetic molecules) were shown to form 
chloride-permeant pores in liposomes (Pajewski et al., 2005). Moreover, Montes et al. 
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(2002) showed that ceramide induced permeability in vesicles regardless of the method of 
delivery (in situ production by the hydrolysis of sphingomyelin by sphingomyelinase or 
by the addition of ceramide from an organic solvent). In addition, molecular dynamics 
simulations of ceramide channels provide some evidence that such channels can be 
legitimate, stable biological structures (Anishkin et al., 2006). The production of reactive 
oxygen species (ROS) by ceramide is well documented (Zamzami et al., 1995; García-
Ruiz et al., 1997; Corda et al., 2001); however, under our circumstances such a 
production should not take place. The mitochondria are uncoupled by 2,4-dinitrophenol 
and hence the protonmotive force is dissipated. Moreover, the mitochondria were not 
supplied with substrates for the respiratory complexes and the endogenous substrates 
should be low in a diluted mitochondrial suspension. Under these conditions, ROS 
production should be minimal if present. Indeed, ceramide can produce ROS and also can 
directly permeabilize membranes. In liposomes, ceramide is able to directly release CF 
without the help of any ROS production. It is evident that ceramide has multiple roles in 
the cell. 
Ceramide metabolism is highly regulated (Hannun, 1996) in a cell and ceramide 
and its metabolites are kept at a steady state level. When the death signal arrives, 
ceramide production is increased by de novo synthesis and/or by sphingomyelin 
hydrolysis (for review, see Pettus et al., 2002). One of the products of the de novo 
synthesis is dihydroceramide which has been shown to be inactive both biologically (does 
not cause apoptosis (Bielawska et al., 1993; Sugiki et al., 2000) and physically (does not 
form channels in planar membranes (Siskind and Colombini, 2000), mitochondria 
(Siskind et al., 2002) or liposomes).  
 
 
During de novo ceramide synthesis (Mandon et al., 1992), serine condenses with 
palmitoyl CoA to form ketosphinganine which is reduced to sphinganine. 
Dihydroceramide synthase then produces dihydroceramide from sphinganine and 














FIG. 3.7. A scheme of de novo ceramide synthesis pathway. 43
Dihydroceramide inhibits ceramide channel formation both in mitochondria and 
 liposomes. This attribute of dihydroceramide may be essential in regulating the effects 
f ceramide in cells. In order to permeabilize mitochondria to start the apoptotic pathway, 
e synthesized ceramide has to overcome the inhibition of channel formation by 
ihydroceramide. A threshold ratio of ceramide to dihydroceramide may be a plausible 
ay to think of the initiation of ceramide-induced apoptosis. Presumably, the formation 
f ceramide from de novo synthesis leads to the decline in dihydroceramide concentration 
nd hence enhances the ceramide effects on mitochondria. Possibly, the synthesis of 
eramide by sphingomyelin is less efficient in channel formation because 
ihydroceramide concentration is not diminished (Kroesen et al., 2001). Moreover, 
hingomyelin and sphingomyelinase are mainly present in the plasma membrane. 
owever, sphingomyelinase added to mitochondria will generate ceramide in 
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mitochondria but this ceramide accumulation was not able to release cytochrome c 
(Birbes et al., 2001). In addition there may be a carrier protein like CERT that shuttles 
ceramide to mitochondria in the same way it does from ER to Golgi and plasma 
membrane (Perry and Ridgway, 2005). Nevertheless, it is quicker and more efficient to 
produce ceramide directly in mitochondria by the de novo pathway in response to a death 
signal, if the intended target is to permeabilize mitochondria through ceramide channels.  
The de novo pathway has been shown to be the one by which ceramide is produced in 
various cell types and as a result of different stimuli (for review, see Perry, 2002). 
Furthermore, inhibition of the de novo enzymes prevented alveolar cell apoptosis 
(Petrache et al., 2005).When treating cells with tumor necrosis factor, isolated 
mitochondria showed a 2-3-fold increase in ceramide levels. This increase was not due to 
the hydrolysis of sphingomyelin but due to de novo synthesis (García-Ruiz et al., 1997). 
Cannabinoids, the active ingredients of marijuana, induced an acute ceramide synthesis 
via sphingomyelin hydrolysis, which mediated the regulation of metabolic functions; and 
a sustained generation of ceramide via the de novo pathway. This production leads to 
apoptosis (Velasco et al., 2005). In addition, ceramide levels increased specifically from 
the de novo synthesis after treating cells with N-(4-hydroxyphenyl)retinamide, an event 
that lead to apoptosis (Darwiche et al., 2005). It is clear that the de novo pathway 
participates more in ceramide production that induces apoptosis. The dihydroceramide 
inhibition of ceramide channel formation may be another indication of the importance of 







Ceramide has been shown before to form channels in planar phospholipid 
membranes (Siskind and Colombini, 2000) and in the outer membrane of mitochondria 
(Siskind et al., 2002). These channels allow proteins to cross membranes and are 
probably large enough to allow the known pro-apoptotic proteins to be released from 
mitochondria.  Here, we demonstrate that ceramides (both long chain and short chain) are 
able to form channels in liposomes in a dose-dependent manner. Furthermore, we 
discovered that dihydroceramide, generally reported to be an inactive precursor, inhibits 
the formation of ceramide channels at a molar ratio indicative of its interfering with 
ceramide nucleation of channel formation.  Thus dihydroceramide is probably acting as 
an inhibitor rather than just being unable to form channels (Siskind et al., 2002) or to 
cause apoptosis (Bielawska et al., 1993; Sugiki et al., 2000). We believe that we have 
uncovered a regulatory system, not based on enzymatic activity, that could have a strong 
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The enzyme, dihydroceramide desaturase, converts the inhibitory precursor, 
dihydroceramide, into the apoptogenic sphingolipid, ceramide.  Ceramide can initiate 
apoptosis by permeabilizing the mitochondrial outer membrane to apoptosis-inducing 
proteins. However, the desaturase is known to be located in the endoplasmic reticulum 
(ER) and here we report only minimal activity in isolated rat liver mitochondria. 
Nevertheless, mitochondria are one of the targets of ceramide-induced apoptosis. Here, 
we show that ceramide synthesized in isolated mammalian ER vesicles from either C8-
dihydroceramide or sphingosine to produce long-chain ceramide, can transfer to isolated 
mitochondria and permeabilize these to proteins.  As expected, the transfer of the long-
chain ceramide is slower.  However, sufficient ceramide is transferred to permeabilize the 
outer membrane to cytochrome c and adenylate kinase. The transfer of sphingolipids is 
bidirectional and non-specific as erythrocyte membranes can also receive the ceramide.  
The ER that is tightly-associated with isolated mitochondria can produce enough 
ceramide to permeabilize the outer membrane.  Thus this ceramide exchange obviates the 
need for a complete ceramide de novo pathway in mitochondria in order for cells to use 





Apoptosis, or programmed cell death, is a mechanism by which cells perish 
without harming surrounding cells. An important form of apoptosis is mediated by 
mitochondria (Crompton, 1999; Birbes et al., 2002).  There are many known factors that 
contribute to the induction of mitochondria-mediated apoptosis, but the factors 
responsible for the crucial decision-making step, the release of proteins from the 
intermembrane space, are still debated.  In addition to generally accepted factors such as 
Bax and Bak, the sphingolipid, ceramide, was shown to be able to form large, stable, 
protein-accessible channels in planar phospholipid membranes (Siskind and Colombini, 
2000), in isolated mitochondria (Siskind et al., 2002) and in liposomes (Stiban et al., 
2006). We believe that elevated ceramide levels in mitochondria are important for cells to 
undergo apoptosis.  
In the cell, ceramide has diverse roles (Hannun and Obeid, 2002; Futerman and 
Hannun, 2004). The two major pathways of ceramide generation are de novo synthesis 
and sphingomyelin hydrolysis. De novo ceramide synthesis occurs on the outer leaflet of 
the endoplasmic reticulum (Mandon et al., 1992) even though there are some ceramide 
metabolic enzymes in mitochondria (Bionda et al., 2004). The de novo synthesis (for 
reviews, see Perry, 2002; Merrill, 2002) involves the condensation of serine with a fatty 
acyl-CoA (normally, palmitoyl-CoA). The reaction, catalyzed by serine 
palmitoyltransferase complex (Gable et al., 2000; Hannun et al., 2001) produces 
ketosphinganine, which, after being reduced to sphinganine (dihydrosphingosine), is 
converted to dihydroceramide by ceramide synthase. The oxidation of dihydroceramide 
at the 4,5 position by dihydroceramide desaturase produces ceramide.   
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Many reports (reviewed in Perry, 2002) point to the importance of the de novo 
pathway in producing the ceramide that is involved in mitochondria-mediated apoptosis.  
Although ceramide generated by sphingomyelinase action has been shown to lead to the 
release of cytochrome c from mitochondria (Birbes et al., 2001) most reports favor the de 
novo pathway. Yet, it is clearly established that a critical enzyme in the de novo pathway, 
the dihydroceramide desaturase (DDase), is located in the ER (Morell et al., 1970; 
Hirschberg et al., 1993) facing the cytosol (Michel and van Echten-Deckert, 1997).  Thus 
the production of ceramide from the de novo pathway for use in mitochondria requires 
either the presence of a mitochondrial DDase or a mechanism for transfer of ceramide 
from the ER to mitochondria.  Another source of ceramide could be the reacylation of 
sphingosine by mitochondrial ceramide synthase.  However, sphingosine is produced by 
hydrolyzing ceramide and thus this reacylation is a salvage pathway.  In this study, we 
provide evidence that the location of ceramide production in a cell does not necessarily 
coincide with its functional site.  We find that mitochondria lack significant DDase 
activity but the well established intimate interaction between ER and mitochondria 
(Pickett et al., 1980; Meier et al., 1981; Katz et al., 1983; Vance, 1990; Marsh et al., 
2001) allows the transport of ceramide from one compartment to another.  Sufficient 




MATERIALS AND METHODS 
Experiments with rats were approved by the University of Maryland Institutional Animal 
Care and Use Committee. 
Materials - C2-dihydroceramide, C8-ceramide, C8-dihydroceramide C16-ceramide, C16-
dihydroceramide and sphinganine were purchased from Avanti Polar Lipids (Alabaster, 
AL). Analytical-grade DMSO (from Fisher) was used to dissolve C2-dihydroceramide 
whereas isopropanol (from Acros Organics) was used to dissolve C8-ceramide, C8-
dihydroceramide, C16-ceramide and C16-dihydroceramide. Horse heart cytochrome c and 
bovine serum albumin (BSA, fatty acid depleted) and cholesterol were from Sigma (St. 
Louis, MO). Sodium ascorbate, sodium borate and 99.9% dry ethylacetate were bought 
from Acros Organics. Radiolabelled 14C-octanoic acid and 3H-sphingosine were from 
American Radiolabeled Chemicals (St. Louis, MO). N-hydroxysuccinimide and 
dicyclohexylcarbodiimide were from Fisher. Thin layer chromatography was performed 
on Analtech (Newark, DE) silica gel plates. 
 
Preparation of radiolabeled C8-dihydroceramide – Sphinganine was acetylated using 1-
14C-octanoic acid (Fig. 4.1), according to the procedure of Schulze et al. (1999). Four 
sealed, septum-topped, argon-flushed reaction vials were used to minimize any contact 
with water vapor or air. In the first vial, 5 µL containing 5 µCi of radioactive octanoic 
acid (specific activity 55 mCi/mmol) was mixed with 13 µL of 10 mg/mL cold octanoic 
acid (in ethylacetate). In total, 1 µmol of octanoic acid was used. The solvent was flushed 
with a stream of argon and then 1 mL of 99.9% ethylacetate was added to the vial. After 
mixing for 5 minutes, the solution was transferred to the second reaction vial which 
already contained 4 µL of 0.25 M N-hydroxysuccinimide (1 µmol) and had been flushed 
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with argon. After mixing for 5 minutes, the solution was injected in the third vial. The 
latter had 1 µmol of dicyclohexylcarbodiimide (1 µL of 1 M). This reaction was carried 
overnight. The next day, the solution was transferred into the fourth vial which contained 
0.87 g (2.6 µmol) of sphinganine. The acylation reaction was carried over 3 days and at 
the end of the third day, the reaction mixture was dried under nitrogen and the products 
were dissolved in 30 µL of CHCl3:CH3OH (1:1, v/v) and applied to a TLC plate. The vial 
was rinsed with 30 µL of CHCl3:CH3OH (1:1, v/v) three times and also applied to the 
TLC plate (to recover essentially all the radioactivity). The developing system was 
CHCl3:CH3OH:H2O (80:10:1, v/v/v). On the TLC, the radioactive band was recovered 
after being detected with a Geiger-Müller counter, scrapped off the gel and extracted in 
CHCl3:CH3OH (2:1, v/v). Multiple extractions of the gel were made. Further separation 
of octanoic acid from the product N-[1-14C]octanoyl-D-erythro-sphinganine, or C8-
dihydroceramide (DHC8*) was not needed since the reaction apparently consumed all 
reactants (as evident by the visualization of the gel in a PhosphorImager screen).  The 





FIG. 4.1. Synthesis of radiolabeled DHC8. 1-14C-octanoic acid and N-
hydroxysuccinimide were mixed and activated by dicyclohecylcarbodiimide. In an 
overnight reaction, dicyclohexylurea precipitated and sphinganine was added to 
the activated fatty acid. The aceylation reaction took 3 days to be completed 
forming  DHC8 and retrieving the N-hydroxysuccinimide.  53
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Mitochondria – Mitochondria were isolated from male Sprague-Dawley rat liver as 
described by Parsons et al. (1966) as modified by (Siskind et al., 2002 and Sitban et al., 
2006). Briefly, livers from overnight-fasted young rats (generally 200 to 300g) were 
obtained and cut in ice-cold isolation buffer (210 mM Mannitol, 70 mM sucrose, 10 mM 
HEPES, 0.1 mM EGTA and 0.05 mg/mL of fatty acid-free Bovine Serum Albumin, pH 
7.4; i.e. HB-buffer). The liver was minced and homogenized in a motorized Potter 
homogenizer with loose Teflon pestle (two passes).  Differential centrifugation followed, 
starting at 760 ×g for 10 minutes at 4 oC. To recover the mitochondria, the supernatant 
was then spun for 10 minutes at 9000 ×g. The supernatant of this spin was used to isolate 
ER (see below). This sequence was repeated but the second high-speed spin was 
performed with HB-buffer lacking BSA (i.e. H-buffer).  Finally the mitochondrial pellet 
was gently resuspended in H-buffer. 
The protein concentration of the mitochondrial suspension was measured by using a 
spectroscopic method (Clarke, 1976). Reduced cytochrome c was prepared by mixing 5.5 
mg of cytochrome c with 2 mg sodium ascorbate in 0.25 mL of buffer Q (200 mM 
HEPES, 10 mM EGTA, pH 7.5). The reduced cytochrome c was separated from the 
ascorbate on a Sephadex G-10 gel filtration column pre-equilibrated with buffer Q (after 
elution, the concentration of reduced cytochrome c is about 1 mM). 
 
Ultra-pure Mitochondria Isolation – Mitochondria isolated by differential centrifugation 
were layered on top on a 28 % self-generating Percoll gradient according to (Holden and 
Colombini, 1993) and the tube was spun at 39,000 ×gmax for 30 minutes. The 
mitochondrial fraction was collected and diluted in H-buffer and spun at 9000 ×g for 10 




The Endoplasmic Reticulum – Here, we use the term ER for the isolated microsomes 
which have different components but are mostly composed of endoplasmic reticulum 
membranes. The ER was separated following the modified procedure (Schulze et al., 
1999). Briefly, the first 9000 ×g supernatant from the mitochondrial isolation was spun 
down at 105,000 ×g for 1 hour. The pellet was suspended in H-buffer. To separate some 
attached mitochondria, another spin of 9000 ×g for 10 minutes followed and the protein 
concentration in the supernatant was determined using the BCA protein assay kit from 
Pierce (Rockford, IL). 
 
Red Blood Cells – Blood from a decapitated rat was collected in a tube pre-filled with an 
anticoagulation buffer (AB) containing 150 mM NaCl, 4 mM EGTA and 5 mM HEPES, 
pH 7.4. Red blood cells were collected by centrifugation of 1 mL of the blood at 600 ×g 
for 10 minutes. The cells were resuspended in AB and pelleted 3 times. After the third 
spin, the cells were osmotically shocked in double distilled water and the membranes 
were spun at 12,000 ×g for 10 minutes. This step was also repeated 3 times. After the last 
run, the membranes were resuspended in AB and the protein concentration was measured 
by the aforementioned assay.  
 
Radioactive Desaturase Assay – Following the protocol of (Schulze et al., 1999) 
radioactive desaturase assays were performed on mitochondrial and endoplasmic reticular 
fractions. One modification was the use of isopropanol to dissolve ceramides and 
dihydroceramides. This solubilization protocol and the concentration of dihydroceramide 
used were effective in preventing the sedimentation of dihydroceramide micelles when 
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the solution was centrifuged at 105,000 ×g to sediment endoplasmic reticulum (more than 
99 % of the radioactivity remained in the supernatant). In contrast, solubilizing ceramide 
in DMSO or ethanol at higher concentrations has problems in its delivery to mitochondria 
(Siskind et al., 2006). 
 
Mitochondrial Inner Membrane Desaturase Assay – 300 µL of 21 mg/mL mitochondria 
were mildly shocked in 0.9 mL of double distilled water and were kept on ice for 5 
minutes. Osmolarity was restored by adding 0.9 mL of R×2 buffer (0.6 M mannitol, 20 
mM NaH2PO4, 10 mM MgCl2, 20 mM KCl pH 7.2). The final concentration of 
mitochondria was 3 mg/mL. To assess the DDase activity, to 1 mL of the shocked 
mitochondria was added 36 µL of the M/G buffer (70 mM malate, 70 mM glutamate, K+ 
salt pH 7.3) to generate NADH in the matrix,  40 µL of 0.1 M NADH (to supply the 
NADH to the medium along with 10 µL of 1-14C-DHC8 ). The reaction was run for 45 
minutes at 37oC before being stopped by the addition of 1.5 mL of CHCl3:CH3OH (2:1, 
v/v). In the control experiment, the reaction was stopped immediately after the addition 
of the radiolabeled compound. The lipids were isolated as described below.   
 
Separation of C8 from DHC8 – The protocol of (Schulze et al., 1999) was followed. 
Basically, a TLC plate impregnated with borax was used to separate ceramide from 
dihydroceramide. A 70 mM suspension of sodium borate in methanol was poured on a 
silica gel TLC plate and incubated for 30 minutes. The plates were removed and dried at 
room temperature for 2 hours. After the lipids were extracted, they were spotted on these 
borax-impregnated plates. The developing system for the separation was 9:1 (v/v) 




Visualization of the radiolabeled bands – After the TLC plates were developed, they 
were air dried and then stored in contact with a PhosphorImager screen (Amersham 
Biosciences) in a dark cassette for a minimum of 3 days. The screen was then scanned in 
a Storm PhosphorImager. 
 
Medium-chained Lipid Transfer Experiments – The transfer of radiolabeled lipids from 
the ER to mitochondria was measured as follows. 750 µL of 3 mg/mL ER was incubated 
with 10 µL of 1-14C-DHC8 and 40 µL of 0.1 M NADH for 45 minutes. An equivalent 
amount of mitochondria was added resulting in a total volume of 1.5 mL.  The tube was 
vortexed and incubated at 37oC for 2, 5 or 10 minutes before being spun down at 9000 ×g 
for 10 minutes. Aliquots were taken from the pellet (mitochondria) and supernatant (ER) 
to measure total radioactivity, then CHCl3:CH3OH (2:1, v/v) was added to each fraction 
to isolate the lipids. The lipids were extracted and run on a TLC plate. The radioactive 
bands were visualized as indicated above.    
 
Long-chained Lipid Transfer Experiments – ER preparations (8.1 mL of 3 mg/mL 
protein) were mixed with 100 µM palmitoyl CoA (900 µL of 1 mM) and 1.5 µL of 3H-
sphingosine (1.5 µCi) (specific activity 20 Ci/mmol) and incubated at 37oC for 15 
minutes (Wang and Merrill, 1999). After incubation, excess sphingosine was removed by 
the addition of 63 mg of fatty acid free BSA and spinning down the ER at 105,000 ×g for 
1 hour. After resuspending the ER pellet in 9 mL of H-medium and distributing it in 3 
tubes, mitochondria (3 mL of 3 mg/mL protein) were gently mixed with the ER 
preparations carrying the radiolabeled ceramide and the tubes were incubated for 0, 5 and 
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10 minutes at room temperature before spinning at low speed (9000 ×g for 10 minutes) to 
recover mitochondria and then high speed (105,000 ×g for 1 hour) to retrieve the ER. 
Aliquots from the pellets were taken to measure the ER marker enzyme. The lipids were 
extracted from the pellets by CHCl3:CH3OH (2:1, v/v) and samples were counted in a 
scintillation counter. The rest of the extracted lipids were dried down under nitrogen and 
house vacuum over night and applied to a TLC. The mobile phase used was 99:1 (v/v) 
diethylether:CH3OH (Wang and Merrill, 1999). The ceramide and sphingosine bands 
were then scrapped and counted to determine the percent conversion. 
 
Functional Desaturase Assay – Mitochondria (50 µL of 3 mg protein/mL) were 
suspended in 0.75 mL of isotonic H-buffer and incubated with 20 µL of 4 mM NADH 
(0.1 mM) and 10 µL of 1 mg/mL DHC16 (19 nmol) for various times. After the 
incubation, the mitochondria were spun down at 6500 rpm for 5 minutes (at 4 oC) before 
being gently resuspended in 0.75 mL of H-buffer supplemented with 2.2 µM antimycin A 
and 2 mM 2,4-dinitrophenol (HAD-buffer). The reduction of absorbance of added 15 µL 
of 1 mM reduced cytochrome c at 550 nm was used as a measure of the permeabilization 
of the mitochondrial outer membrane (Siskind et al., 2002; Stiban et al., 2006).  Vehicle 
controls were performed as appropriate. 
 
Monitoring Outer Membrane Permeability After Exposure to ER – Isolated ER (2 mg 
protein) were preincubated with 3 µmol NADH and 28 nmol DHC16 in 1 mL of H-buffer 
for 0, 20, 45 and 80 minutes. The control lacked NADH and DHC16. At each time point, 
50 µL of the ER (control or experimental) was mixed with 50 µL of 0.5 mg protein/mL 
mitochondria in 0.75 mL of HAD-buffer and incubated for 10 minutes before 15 µL of 1 
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mM reduced cytochrome c was added to measure the cytochrome c oxidation rate (an 
indication of the outer membrane permeability to cytochrome c). The difference in 
absorbance at 550 nm and 600 nm was used to record the cytochrome c oxidation 
because adding ER to mitochondria caused an increase in the light scattering with time 
(increasing the baseline at 600 nm). Also, incubating the ER by itself (no mitochondria) 
had a baseline of cytochrome c oxidation, indicating some contamination with 
mitochondria. The baseline rate of cytochrome c oxidation by ER vesicles was subtracted 
from the rate measured in each experimental treatment with ER 
 
The Release of Adenylate Kinase –Isolated mitochondria (200 µg protein) were incubated 
in 3 mL of H-buffer and 1 µL of 5 mg/mL leupeptin, 1 µL of 5 mg/mL aprotinin and 1 µL 
of 5 mg/mL pepstatin. This was the control, untreated sample. At time points 0, 5 and 15 
minutes, 1 mL was taken out and spun at 14,000 rpm. 900 µL of the supernatant was 
recovered and put on ice. In each experiment, 300 µL of the supernatant was mixed with 
700 µL of the reaction mixture (RM) containing: 50 mM Tris (pH 7.5), 5 mM MgSO4, 10 
mM glucose, 1 mM ADP and 0.2 mM NADP+. After waiting for a minute, 9 µL of the 
enzyme mixture (25 units of hexokinase and 25 units of glucose-6-phosphate 
dehydrogenase) was added and the production of NADPH at 340 nm was monitored. In 
the experimental trials, 2.4 mM NADH or 74 nmol DHC16 or 2.4 mM NADH + 74 nmol 
DHC16 were added to the control mixture. The rest of the procedure was similar. 
 
ER Marker Enzyme Assay – The marker enzyme for the ER was NADPH:cytochrome c 






A dihydroceramide desaturase capable of using cytosolic NADH is not found in 
ultra pure mitochondria 
Previous studies showed that some ceramide metabolic enzymes are found in 
mitochondria. We looked for the activity of the DDase in isolated mitochondria. Isolated 
mitochondria prepared by differential centrifugation, ultra pure mitochondria and 
microsomes were assessed for their ability to convert 1-14C-DHC8 to 1-14C-C8-ceramide 
using the DDase assay of Schulze et al. (1999).  Unlabeled sphingolipids were added to 
the samples at the end of the incubation period to act as carriers and to confirm separation 
on the TLC.  Microsomes, largely composed of endoplasmic reticulum (ER) vesicles 
(Fig. 4.2, ER) showed the largest conversion (44 ± 5 % in 45 minutes, average and 
standard deviation of 23 experiments). Mitochondria isolated by differential 
centrifugation (DC-mitochondria) also had some significant conversion indicating that 
mitochondria might have a small amount of the enzyme or some associated ER vesicles 
(as previously reported, Pickett et al., 1980 and Katz et al., 1983) (Fig. 4.2, M). In the 
Percoll gradient-purified mitochondria the DDase activity was not seen. The Percoll step 
seems able to disassociate the two organelles.  The results for these ultra pure 
mitochondria indicate that the enzyme is not found in mitochondria in a detectable 
amount (Fig. 4.2, UP) but the tight interaction between mitochondria and ER is what 
causes this conversion in the DC-mitochondrial fraction. Following an ER marker 
enzyme assay (NADPH:cytochrome c reductase), the DC-mitochondria had double the 
activity (13.5 µM mg-1min-1) of the ultra pure (5.8 µM mg-1min-1) but significantly less 






Ultra pure mitochondria isolated from rat liver have minimal DDase activity in both 
membranes 
To check whether the DDase is found in the inner membrane of mitochondria 
utilizing matrix NADH, NADH was produced in the matrix using the malate/glutamate 
shuttle (Rickwood et al., 1987). The mitochondria used here were Percoll-purified with a 
broken outer membrane to allow maximal accessibility to the inner membrane. Thus 4 
mM NADH was present in the medium while NADH was maintained high in the matrix 
by the malate/glutamate shuttle.  The TLC (Fig. 4.3A) shows virtually no difference 
 
FIG. 4.2. DDase capable of using cytosolic NADH was not found in mitochondria. 
(A) A PhosphorImager screen of a TLC gel showing the conversion of added 
radioactive 1-14C-DHC8 to radioactive 1-14C-C8 in different cellular fractions: no 
organelles (C), ultra pure mitochondria (UP), mitochondria obtained by differential 
centrifugation (M), and endoplasmic reticulum (ER). (B) Iodine staining of the same 
gel. Cold DHC8 and C8 was added to each sample prior to extraction so that it would 
act as a carrier for the label and to clearly indicate the location of the two compounds 
on the TLC plate. The lipids were extracted from the same amounts of organellar 
protein (0.6 mg of protein per lane, except for “C”).  All the extracted lipid was 
applied to the TLC plate. Mitochondria were purified on a Percoll gradient. 
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between zero min of incubation (BMcont) and 45 min of incubation (BM). Subtraction of 
the curves (Fig. 4.3B) shows a slight radioactive ceramide peak consistent with about 8.4 
± 1.3 % conversion.  This is 3.7 % of the specific activity in the ER. For comparison, the 
NADPH:cytochrome c reductase marker enzyme activity was 3.2 % and 1.4 % of the 
specific activity of the ER in DC- and Percoll-treated mitochondria, respectively. 
Recovered ER from the Percoll-treated mitochondria showed the same conversion of 
dihydroceramide to ceramide, ruling out that Percoll inhibits this enzyme.  




FIG. 4.3. The DDase associated with mitochondria is minimal. (A) A 
PhosphoImager screen of a TLC plate showing minimal conversion of 1-14C-DHC8
to 1-14C-C8* in Percoll-purified mitochondria with broken outer membrane supplied 
with NADH externally and maintained in the matrix by providing 
malate/glutamate.  Sample “BM” was incubated for 45 min and sample “BMcont” 
was incubated for zero time.  The traces were quantified as a function of migration 
distance in pixels and plotted in (B). The inset shows the subtraction of the zero-
time control from the experimental sample, BM. A peak possibly attributable to 
ceramide was detected whose area corresponds to 8.4 ± 1.3 % conversion in 45 
minutes per 3 mg of protein. This is the average of 3 independent experiments ± 
standard deviation (in contrast, the microsomal fraction achieved 44 ± 5 % 
conversion in 45 minutes with 0.6 mg of protein). 
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Medium-chain DHC8 and C8 and long-chain C16 in the ER can be transferred to 
mitochondria in a time dependent manner 
The deficiency in mitochondrial DDase activity would indicate that mitochondria 
would have difficulty in generating ceramide from the de novo synthetic pathway. 
However, the proximity of ER and mitochondria raises the possibility of transfer of lipids 
between these compartments. To investigate this possibility, radiolabeled ceramide was 
generated in the ER by incubating these with NADH and 1-14C-DHC8. After 45 min these 
were incubated with mitochondria for 10 min followed by separation of the organelles by 
differential centrifugation. The ER marker enzyme assay was used to determine the 
effectiveness of separating ER from mitochondria and the separation was effective (only 
1.4 % of the ER marker enzyme activity was recovered in mitochondria). Lipid 
extractions were performed followed by separation of ceramide from dihydroceramide on 
TLC (Fig. 4.4A). Ceramide and dihydroceramide bands were present in both 
mitochondria and ER. The transfer of these lipids occurred with a half-life of 5-10 
minutes (Fig. 4.4B). A similar rate of transfer was seen in the reverse direction (data not 
shown). In order to test for specificity of transfer between ER and mitochondria, we 
tested the transfer to erythrocyte membranes (Fig. 4.4C). The rate was essentially the 
same indicating that we are observing the rate of spontaneous transfer of C8-ceramide 
between membranes. This rate has not been reported in the literature, so we decided to 
estimate it from the published rates of transfer of C16-ceramide. The rate of transfer of 
ceramide from the donor membrane can be calculated from the results of Simon et al. 
(1999) by using Eyring rate theory and an energy deficit of 3 kJ/methylene molecule. 
Thus, for C8-ceramide, the rate constant for this process is 1.6 min– 1. So, an exchange of 
15 % should occur within 70 seconds. This is consistent with our observations 
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considering that there are other steps in the exchange process. These become significant 
when the transfer rate out of the membrane is fast. 
We examined the possibility that a mechanism might be present to accelerate 
ceramide transfer from ER to mitochondria. The rapid spontaneous transfer of C8-
ceramide did not allow us to detect such a mechanism; therefore we examined the 
transfer rate of C16-ceramide. Exchange experiments were performed with endogenously-
produced 3H-C16-ceramide. 3H-sphingosine and palmitoyl coenzyme A were added to ER 
preparations to endogenously synthesize 3H-C16-ceramide in the ER membrane using the 
enzyme ceramide synthase. Excess sphingosine was removed with BSA. Fig. 4.4D shows 
that the transfer of the ceramide from ER to mitochondria occurs in a time-dependent 
manner at a rate much faster than that of spontaneous transfer (35 h for 20 % transfer) 
(Simon et al., 1999). Therefore, the ER must contain some system to catalyze the egress 




















ThG. 4.4. Both medium and long-chain ceramide transfer from ER to mitochondria or 
C in a time dependent fashion. (A) A PhosphorImager screen of a TLC showing 
e transfer of medium-chain ceramide from ER to mitochondria. After the production 
 ceramide in the ER, Percoll-treated mitochondria were incubated with the ER for 
e indicated times and then the organelles were separated by centrifugation. The 
ids were extracted from the low speed spin pellet (M) and the high speed spin pellet 
R). Equal amounts of protein were used in these experiments. (B) The percentage 
tal radioactivity recovered in the mitochondria (●) and ER (○) is shown as an 
erage of 4 separate experiments ± S.E.M. (C) ER vesicles containing labeled 
edium-chained ceramide and dihydroceramide were incubated with RBC 
embranes for the indicated times followed by separation and quantitation of the 
dioactivity. (D) ER vesicles were preloaded with radiolabeled long-chain ceramide 
d incubated with mitochondria at room temperature for 0, 5 and 10 min resulting in 
slow but steady transfer of ceramide from the ER (●) to mitochondria (○). 
itochondria were checked for the percent ER marker enzyme contamination (▼). 
e result represents the average ± S.E.M. of 3 replicates. 65
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The transfer of long-chain ceramide into mitochondria depends on the 
concentrations of organelles used 
 Determining the mechanism of this transfer was critical. If the transfer of 
ceramide between ER and mitochondria occurred because of random collision between 
these organelles then the transfer rate should depend on the concentration of these 
organelles in the assay.  A bimolecular process depends on the product of the 
concentrations of the reactants.  Thus reducing the concentrations of each of the 
interacting organelles by half, the transfer rate should drop by a factor of 4.  Other 
processes would predict different outcomes.  For example if the organelles adhered to 
each other then the dilution would have a much weaker effect.  The results obtained were 
334 ± 36 DPM for the undiluted sample and 99 ± 14 DPM for the diluted sample.   This 
result is not significantly different from a four-fold dilution effect.  It is significantly 
different from both a 2-fold effect (P<0.02) and from no dilution effect (P<0.005).  The 
results represent the average and standard error of 3 experiments. Hence, this shows that 
the transfer occurs by random collision of the organelles. 
 
Incubating mitochondria with NADH and long-chain dihydroceramide 
permeabilizes the outer membrane to adenylate kinase and cytochrome c 
The addition of ceramide to isolated mitochondria leads to the permeabilization of 
the outer membrane to proteins (Siskind et al., 2002; Stiban et al., 2006, Siskind et al., 
2006). Since we have shown that ceramide produced in the ER can rapidly transfer to 
mitochondria, mitochondria with associated ER may be capable of acting as a functional 
unit.  Dihydroceramide conversion in the mitochondria-associated ER may permeabilize 
the mitochondrial outer membrane to proteins.  Mitochondria isolated by differential 
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centrifugation were incubated with NADH and long-chain DHC16 and samples tested as a 
function of time for permeability to cytochrome c (Fig. 4.7A) or the release of adenylate 
kinase (Fig. 4.5B).  As adenylate kinase leaks out it accumulates in the medium and thus 
even low or transient permeabilities will result in its release.  The cytochrome c oxidation 
assay measures the permeability of the outer membrane to cytochrome c as the rate of 
cytochrome c oxidation.  Thus this assay monitors the actual permeability as a function of 
time.  Note that the permeability peaks followed by a reduction possibly due to the 
movement of ceramide into other non-conducting structures.  Incubating the 
mitochondria with NADH alone, NAD+, or NAD+ plus DHC16 did not induce 
permeabilization more than the control, untreated mitochondria (Fig. 4.5A, C) indicating 
that the permeability is due to the production of long-chain C16-ceramide by the DDase in 
the ER and its transfer to mitochondria.  Short-chain dihydroceramide (DHC2) was 



























FIG. 4.5. Permeabilization of mitochondrial outer membranes to cytochrome c and adenylate
kinase following generation of ceramide by associated ER vesicles.  (A) The outer membrane
permeabilization to cytochrome c was measured by recording the cytochrome c oxidation rate
and expressed as a percent of the rate observed with hypotonically shocked mitochondria. The
cytochrome c oxidation rate was measured after incubation of rat liver mitochondria for the
indicated time at 20oC (●) and 37oC (○). The amounts of NADH and DHC16 are identical to
the amounts in (C). (B) The release of adenylate kinase increases when the mitochondria are
incubated with NADH and DHC16. Mitochondria were incubated for the indicated amount of
time with either NADH alone (○) NADH plus DHC16 (▼) or no treatment (●) followed by
quantitating the amount adenylate kinase released into the medium.  Treating the
mitochondria with DHC16 alone (not shown) did not lead to adenylate kinase activity in the
supernatant. This is expressed as a percent of the total activity released following hypotonic
shock. (C) The production of ceramide by dihydroceramide desaturase in DC-mitochondria
permeabilizes the mitochondrial outer membrane to cytochrome c. 50 µL of 3 mg/mL rat liver
mitochondria obtained by differential centrifugation were incubated with the indicated
compounds for 30 min followed by centrifugation to remove the supernatant (especially the
NADH).  This extra step caused some mitochondrial damage (high control).    Treatment with
0.1 mM NADH and 19 nmoles DHC16 (but not DHC2) resulted in the permeabilization of the
outer membrane. The percent permeabilization is the rate of cytochrome c oxidation as a
percent of that observed with hypotonically shocked mitochondria.  All the results are




Mitochondrial outer membrane permeabilization by interaction with long-chain 
ceramide-containing ER vesicles  
 Aliquots of mitochondria were mixed either with ER vesicles pretreated with 
NADH and DHC16 to preload them with ceramide, or untreated ER vesicles, or medium 
alone.  The mitochondria-ER combinations were incubated for the indicated times (Fig. 
4.6) and then the cytochrome c oxidation rate was measured.   The permeabilization of 
the outer membrane to cytochrome c is once again expressed as a percent of the rate 
observed with shocked mitochondria.  Only mitochondria exposed to ER vesicles 








 addition of ceramide-containing ER to DC-mitochondria induced 
n to cytochrome c. Mitochondria were incubated for the indicated 
 with either untreated ER vesicles (○), ER vesicles pretreated with 
C16 (▼) or no treatment (●) followed by measurement of their ability 
chrome c.  The permeabilization is the cytochrome c oxidation rate 
 percent of the total oxidation rate following hypotonic shock. The 




In the cell, lipid biosynthesis sometimes requires that intermediates move from 
one cell compartment to another. For instance, the endoplasmic reticulum is the main site 
of lipid biogenesis but mitochondria also play a role. Most of the enzymes of the 
phospholipid synthetic pathway reside in the ER (Bishop and Bell, 1988). However, 
some enzymes such as phosphatidylserine decarboxylase are located in mitochondria 
(Dennis and Kennedy, 1972). This enzyme is critical for the formation of 
phosphatidylethanolamine (PE) from phosphatidylserine (PS) (Dennis and Kennedy, 
1972; Voelker, 1989; Vance, 1991).  Thus, the synthesis of PE requires that PS, made in 
the ER, move into mitochondria where it is decarboxylated forming PE which returns to 
the ER (Vance, 1990; Vance, 1991; Shiao et al., 1995; Gaigg et al., 1995; Vance and 
Shiao, 1996).  
The mechanism of PE and PS translocation between the ER and mitochondria has 
been investigated extensively and, while questions remain, the evidence indicates that 
membrane contact between the ER and mitochondria is responsible for rapid lipid 
exchange (reviewed comprehensively in Daum and Vance, 1997 and Voelker, 2005) 
rather than vesicular transport (Voelker, 1989; Vance et al., 1991).  A close interaction 
between ER and mitochondria has been inferred from functional studies (Meier et al., 
1981; Vance, 1990) and observed ultrastructurally (Pickett et al., 1980; Katz et al., 1983; 
Marsh et al., 2001).  Thus direct exchange of lipids between these compartments is the 
most likely mechanism and may be a general process. 
The import of other phospholipids from the ER into mitochondria has also been 
studied (reviewed in Daum and Vance, 1997) but the exchange of sphingolipids has not. 
Sphingolipids are known to be transferred from the ER to Golgi and plasma membrane 
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by vesicular transport (reviewed in van Meer and Lisman, 2002; Futerman and Riezman, 
2005) but it is not known how and whether sphingolipids travel between ER and 
mitochondria. Ceramide, the critical sphingolipid which induces apoptosis in a variety of 
ways, is synthesized in the ER by the de novo pathway but is also found in mitochondria 
(Bionda et al., 2004).  There, ceramide permeabilizes the outer membrane to apoptotic 
proteins signaling the start of irreversible mitochondria-based apoptosis (De Maria, 
1997). Some enzymes in the ceramide synthetic pathway are found in mitochondria such 
as ceramide synthase (Bionda et al., 2004) and neutral ceramidase (El Bawab et al., 
2000) but typically the former enzyme produces dihydroceramide, the inactive precursor. 
We found that the critical dihydroceramide desaturase (DDase) needed to generate 
ceramide from dihydroceramide is lacking in both mitochondrial membranes, thus 
indicating that complete de novo synthesis in mitochondria requires sphingolipid 
exchange with the ER.   However, it is possible that mitochondrial DDase activity is 
absent or suppressed under normal conditions but becomes introduced or activated under 
special circumstances, e.g. during the initiation of apoptosis.   
We found that both ceramide and dihydroceramide can exchange between ER and 
mitochondrial membranes. Using the DDase to oxidize 1-14C-DHC8 to 1-14C-C8 in the 
ER, we were able to find substantial transfer of both lipids to mitochondrial membranes. 
Since 1-14C-C8 was made in the ER membrane, all radiolabeled ceramide in mitochondria 
must have come from the ER. Of the total added 1-14C-DHC8, 75 % inserts in the ER 
membrane and the rest remains in the buffer. The reverse was also true. Incubating 
mitochondria with 1-14C-DHC8 before mixing them with ER led to an equal distribution 
of radioactivity in both membranes after 10 minutes of incubation. Furthermore, long-
chain 3H-C16-ceramide, made in the ER by radiolabeled 3H-sphingosine and palmitoyl 
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CoA, can also transfer to mitochondria, although slower than the medium-chained 
ceramide, as expected.  
The mitochondrial ceramide level is important because elevation of ceramide 
levels in the outer membrane leads to the release of pro-apoptotic proteins. In a variety of 
systems, the steady state level of ceramide increases in mitochondria when the cell is 
preparing to undergo mitochondria mediated apoptosis (De Maria et al., 1997; Zamzami 
et al., 1995; Castedo et al., 1996; Susin et al., 1997; Pettus et al., 2002). This increase 
coincides with the permeabilization of the outer membrane to intermembrane space 
proteins. This is not merely a correlation because the addition of ceramide to isolated 
mitochondria induces the release of cytochrome c from the intermembrane space (Arora 
et al., 1997; Ghafourifar et al., 1999; Di Paola et al., 2000). The permeability of the 
mitochondrial outer membrane to proteins is enhanced by the incubation with ceramide in 
a dose- and time-dependent manner (Siskind et al., 2002). This release of pro-apoptotic 
proteins (cytochrome c, Smac/DIABLO, AIF, etc.) starts the execution phase of apoptosis 
(Saelens et al., 2004).   
Among the various pro-apoptotic activities of ceramide (reviewed in Siskind, 
2005), direct channel formation in the outer membrane accounts for the protein release.  
Ceramide forms channels traversing that membrane (Siskind et al., 2002; Stiban et al., 
2006; Siskind et al., 2006) and forms large, stable and highly organized channels in 
planar phospholipid membranes (Siskind and Colombini, 2000; Siskind et al., 2003) and 
liposomes (Stiban et al., 2006). Ceramide channels were also reported to be able to 
enhance solute efflux (Montes et al., 2002) and release chloride ions (Pajewski et al., 
2005) from lipid vesicles. Molecular dynamics simulations support the stability and 
validity of the proposed ceramide channel structure (Anishkin et al., 2006). 
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The formation of ceramide channels in mitochondria requires the elevation of 
steady state levels of ceramide. We show that de novo ceramide synthesis in the ER is 
sufficient to induce mitochondrial outer membrane permeability. Not only is ceramide 
exchanged quickly between ER and mitochondria, but also the small amount of ER 
associated with mitochondria isolated using differential centrifugation is able to produce 
ceramide and permeabilize the outer membrane to cytochrome c and adenylate kinase 
when the substrates of the DDase are provided. Thus, ER and mitochondria form a 
functional unit for ceramide generation and the release of proteins from mitochondria. 
This functional unit obviates the need for a duplicate set of metabolic enzymes in 
both membrane systems.  The ER has a complete de novo ceramide metabolic pathway so 
why are there any enzymes of this pathway in mitochondria?  Ceramide synthase can 
convert both sphingosine and sphinganine to ceramide and dihydroceramide, 
respectively.  In the de novo pathway, sphinganine is the precursor of ceramide and 
sphingosine is the product of ceramide hydrolysis.  However, in the mitochondria the 
synthase may be used to recycle sphingosine into ceramide.  Thus the activities of 
mitochondrial ceramide synthase and ceramidase may act to bias the system toward or 
away from apoptosis by controlling the steady-state ceramide level.  This is a distinct 
function from the ER de novo pathway. 
  The mechanism of exchange of sphingolipids between ER and mitochondria 
likely occurs through membrane contact resulting from the close apposition of these 
organelles.  Other mechanisms such as vesicular trafficking and protein-mediated 
exchange seem unlikely under the conditions of the experiments reported here but may 
well occur in intact cells. The quick transfer seen here tends to rule out the need for a 
vesicular transport system. An enzyme like CERT (Perry and Ridgway, 2005; Hanada, 
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2006) might be responsible for such a lipid trafficking if it were not for the fact that the 
differential centrifugation process removed the cytosolic proteins.  Moreover, we showed 
that lipids can be transferred at similar rates from ER to either erythrocyte membranes or 
mitochondria. This non-specificity is consistent with simple membrane contact.  In vivo, 
the cellular organization determines which membranes come in contact and thus where 
exchange occurs.   
In conclusion, the elevation of mitochondrial ceramide levels that leads to protein 
release and end-stage apoptosis may arise from the synthesis of ceramide in the ER 
followed by rapid exchange to mitochondria at sites of close contact between these two 
organelles. The mitochondria lack the requisite DDase needed for independent complete 
de novo ceramide synthesis but has enzymes that may regenerate ceramide from the 
hydrolysis product, sphingosine.  This ER-mitochondria collaboration is another example 
of cellular functions requiring the cooperative activity of both and leads us to support the 
notion of an ER-mitochondria functional unit.  
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The method by which mitochondrial intermembrane space proteins are released 
into the cytosol to start the process of programmed cell death, or apoptosis, is still 
debated. The sphingolipid ceramide is a major player that mediates intrinsic apoptosis. 
One method of ceramide action that was proposed by our group involves the formation of 
organized ceramide channels in the mitochondrial outer membrane. In this study, we 
validated this claim by visualizing ceramide pores in liposomes using transmission 
electron microscopy. Those channels were of various sizes, averaging 10 nm in diameter. 
Using electrophysiological techniques, the estimated size of ceramide channels, judged 
from the conductance in a planar phospholipid membrane, was again around 10 nm in 
diameter. Moreover, those channels are large enough to allow the pro-apoptotic 
intermembrane space proteins to be released to initiate apoptosis; hence ceramide 






Mitochondria are at the center of cell viability (production of energy) and 
mortality (programmed cell death, or apoptosis). The release of intermembrane space 
proteins from mitochondria is a key step in the initiation of the apoptotic pathway. There 
is recent evidence that this release occurs through a large pore because the release occurs 
simultaneously for many intermembrane space proteins, such as cytochrome c, Omi, 
Smac and adenylate kinase-2 (Muňoz-Pinedo et al., 2006). The pore is also proposed to 
be open for a long time because even though the onset of the release of AIF occurred 
with the rest of the proteins, it was slower (Muňoz-Pinedo et al., 2006). The nature of this 
pore, however, is still under investigation. In concert, the sphingolipid ceramide was 
shown to initiate apoptosis and release intermembrane space proteins. 
In the past decade, the interest in the sphingolipid, ceramide, and its role in 
ceramide-mediated apoptosis resulted in a large amount of research (for example: 
Hannun, 1996; Decaudin et al., 1998; Jacotot et al., 1999; Tomassini and Testi, 2002; 
Taha et al., 2006). Many mechanisms of action of ceramide have been proposed 
(reviewed in Hannun and Obeid, 2002 and more recently Siskind, 2005).Whereas it is 
established that ceramide can interact with different cellular components and change or 
attenuate their function, its direct effect on mitochondria is becoming widely accepted. 
Our group was first to introduce the notion of large, ceramide-based channels being able 
to be formed in planar phospholipid membranes (Siskind and Colombini, 2000). Since 
ceramide was shown to lead to the release of pro-apoptotic proteins from mitochondria, 
the ceramide channel hypothesis was tested and validated on isolated mitochondria 
(Siskind et al., 2002). We followed by the biophysical characterization of these channels 
(Siskind et al., 2003). The ability of ceramide to permeabilize unilamellar liposomes was 
 
 79
also demonstrated (Stiban et al., 2006). Molecular dynamics simulation of the proposed 
structure of self-assembled ceramide channels showed that such a structure can exist in a 
biological environment (Anishkin et al., 2006). 
Functional studies of ceramide permeabilizing lipid bilayers (Siskind and 
Colombini, 2000), mitochondria (Siskind et al., 2002) and liposomes (Stiban et al., 2006) 
as well as molecular dynamics simulations (Anishkin et al., 2006) indicate that these 
channels are valid structures. Nevertheless, direct structural evidence on the existence of 
these channels was still lacking. Here we show that using osmium tetroxide fixation and 
uranyl acetate negative staining of diphytanoyl phosphatidylcholine (DPhPC)-cholesterol 
liposomes incorporating ceramide allows the visualization of these structures under a 




MATERIALS AND METHODS 
Materials 
Diphytanoyl phosphatidylcholine (DPhPC), asolectin (soybean phospholipids polar 
extract) and ceramides were from Avanti Polar Lipids (Alabaster, AL). Cholestrol was 
from Sigma (St. Louis, MO). 
 
Electrophysiological Recordings 
Using the planar membrane technique (Montal and Mueller, 1972; Schein et al., 
1976) as modified (Colombini, 1987), ceramide channels were studied. The lipids used to 
form the membrane were hexane-based containing 5:5:1 DPhPC, asolectin, cholesterol 
(w/w/w). Lipid monolayers were used to form a bilayer. The current is measured as the 
voltage across the membrane is clamped. The aqueous solution contained 100 mM KCl, 
5mM MgCl2, 5mM PIPES (pH 7.0). All the experiments were performed at room 
temperature. The voltage is controlled in the cis-side. Ceramide was added to both sides 
of the chamber, typically 25 µL of 0.1 mg/mL or 2.5 µL of 1 mg/mL. The ceramide 
solution was made in DMSO.  
 
Conversion between Conductance and Size 
The conversion between the conductance (reciprocal of the resistance) and the 
radii is according to the equation (Hille, 2001): 








 += ,                                              Eq. (1)  
where Rchannel is the resistance of the channel (which equals 1/conducatance of the 
channel); l is the length of the channel (about 5 nm, the length of the bilayer); a is the 
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radius in nm of the channel and ρ is the resistivity of the solution (which is equal to 0.775 
nm/nS for 0.1 M KCl solution). The radius of a channel can therefore be written as a 
function of the conductance by solving the quadratic equation and using the positive root: 
                                                 
16.5
8.322 GGGa ++= .                                              Eq. (2) 
 
Conversion between Molecular Weight and Size 
The conversion between the molecular weight of a globular protein and its radius is 
according to the equation (Tinoco et al., 2002): 


















υ .                                                 Eq. (3) 
where R is the radius of the sphere, Mr is the molecular weight, υ is the partial specific 
volume of proteins (about 0.74 cm3/g) and NA is Avogadro’s number. 
 
Liposome Formation 
DPhPC:cholesterol (94:6 mole percent) liposomes were made. Breifly, 500 µL of 
4 mg/mL DPhPC were mixed with 60 µL of 1 mg/mL cholesterol were mixed and dried 
under nitrogen. The dried lipids were left in house vacuum overnight. 
Using 10 mM NaCl, 10 mM HEPES, 1 mM EDTA, pH 7.2, the liposomes were 
reconstituted. After letting the liposomes swell for 3 minutes, a cycle of freeze-thaw-
sonication (4 times) was performed followed by a freeze-thaw and extrusion (17 times 
through a 0.2 µm polycarbonate membrane) cycle. 
The extruded liposomes were then diluted to 8 mL with buffer. Then, they were divided 
into 4 vials. Ceramide (C16) and dihydroceramide (DHC16) were added as 40 µL of 1 
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mg/mL solution in isopropanol. The control contained 40 µL of isopropanol. Each vial 
was then diluted to 8 mL with buffer and spun for 105,000 g for 4 hours at 4oC. The 




An electron microscope grid was floated on a drop of liposomes for 5 minutes, 
and then was blotted dry using a filter paper. The grid was then floated on a drop of 2% 
OsO4 for 5 minutes before blotting it. Finally, the grid was put on top of a 1% aqueous 
uranyl acetate solution for 1 minute. The grid was blotted and visualized by TEM.  
 
Transmission Electron Microscopy 




Mitochondria were isolated by differential centrifugation per previously published 
methods (Parsons et al., 1966; Siskind et al., 2002; Stiban et al., 2006). 
 
Protein Release, SDS-PAGE, BN-PAGE and Gel Filtration 
 Mitochondria (2.4 mg protein) were treated with protease inhibitors (20 µM 
PMSF, 1 µg/mL leupeptin, 1 µg/mL pepstatin, 10 µg/mL chymostatin, 4 µg/mL 
aprotinin). The mitochondria were then incubated with 240 µg C16-ceramide (120 µL of 2 
mg/mL in isopropanol), 40 µg C16-ceramide or 120 µL isopropanol (control) or shocked 
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in double distilled water. After 10 minutes at room temperature, the mitochondria were 
spun down (30,000 rpm for 30 minutes at 4oC) and the supernatant was collected and 
concentrated in Amicon centricon tubes (5,000 g for about 1.5 hours). The concentrated 
proteins were collected in volumes between 70 and 80 µL. Those proteins were then 
loaded separately on a Sephacryl S-200 gel filtration column (30 mL total bed volume). 
Proteins in the eluted volume were detected by a UV-light monitor measuring the 
absorbance at 280 nm and the traces were recorded on the computer by Clampfit 
software.  
Alternatively, the proteins were assayed using SDS-PAGE on 12% pre-made gels from 





RESULTS AND DISCUSSION 
Ceramide channels are visualized by TEM 
Figure 5.1A and B show two fields of liposomes with ceramide channels (arrows), 
whereas in C a control group of liposomes that does not have ceramide (no observable 
stained spots) is shown. Many controls were done using vehicle (isopropanol) only or 
dihydroceramide (a non-apoptogenic, non-channel former) and they indeed show no 




FIG. 5.1. Ceramide channels are visualized by TEM. DPhPC liposomes with (A and 
B) or without (C) ceramide were fixed with 2% OsO4 and stained with 1% uranyl 
acetate. Ceramide channels were stained and can be seen by the pointed arrows. The 
bars represent 100 nm. 
 
 
The diameter of ceramide channels is around 10 nm 
Using the same lipid DPhPC combined with asolectin (a soy bean extract of 
lipids) planar phospholipid membranes were tested for the capability of ceramide to 
induce pores in them. As previously reported from our group (Siskind and Colombini, 
2000), both long and short chain ceramides are able to form pathways (channels) across 
planar phospholipid membranes that allow metabolites and proteins to pass through. 
These channels can be very large, according to their conductance. In a typical planar 
membrane experiment (Fig. 5.2), short- or long-chain ceramide is added to a zero-
conductance membrane. After some time, ceramide self-assembles into forming a 
channel in the membrane allowing current to flow and the conductance grows.   
FIG. 5.2. Ceramide channel growth in a planar phospholipid membrane. A trace of 
ceramide conductance increase in a planar phospholipid bilayer as a function of 
time. Also, the channel diameter is plotted on the y-axis and this was calculated 
from the equation as explained in materials and methods. The ceramide was added 




As shown previously (Siskind et al., 2003), the conductance represents a single 
channel growing in size rather than a set of small pores in the planar membrane. 
Therefore, the total membrane conductance of this channel can be indicative of its 
diameter. After the membrane has reached a steady level of conductance, this 
conductance is measured and, from equation 2, the diameter was calculated. The range of 
ceramide channel radii in planar membrane experiments varied from less than 1.3 nm (<1 
nS of total membrane conductance) to about 88.3 nm (220 nS). The diameter of the 
channels was determined for many records achieving maximal conductance and the data 
were pooled in a histogram (Fig. 5.3 (bottom and inset)). From the electrophysiological 
recordings, the channel size distribution followed a Gaussian with a preference for a 
diameter around 5 to 15 nm. The inset to this figure is the full trace of all the diameters of 
channels observed. Jointly, many pictures were taken for ceramide channels visualized by 
TEM. The diameter of the stained spot was measured and it varied from channel to 
channel. Again, the distribution of diameters adheres to a Gaussian with an average size 
of 15 nm (Fig. 5.3 (top)). This is a large channel (considering the bilayer thickness of 5 










 5.3. The preferable diameter of ceramide channels is between 5 
15 nm. Histograms of channel diameters measured by electron 
oscopy (top) and electrophysiology (bottom) are shown. In 
etic systems (liposomes, top and planar membranes, bottom), 
ide channels have a preference for diameters between 5 and 15 87
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Ceramide channels have a cutoff size between 115 – 135 kDa 
 After determining the size of the channel in 2 synthetic systems, we decided to 
determine the physiological size of the channel by looking at the size of the proteins that 
are released from mitochondria following ceramide addition. Previously, our lab showed 
that ceramide added to mitochondria caused a release of proteins up to a molecular 
weight of 60 kDa (Siskind et al., 2002). Ceramide was added from an ethanol stock 
solution and only 15 % of the total intermembrane space proteins were released. Here we 
optimized the addition and insertion of ceramide into mitochondria and had a percent 
release of about 60-90 %, using isopropanol as the vehicle and adding ceramide while 
vortexing. The cutoff size of ceramide channels in mitochondria was measured by two 
methods: SDS-PAGE and gel filtration. Mitochondria were either shocked by dilution in 
double distilled water to release all the intermembrane space proteins, or treated with 
different doses of C16-ceramide. The released proteins were concentrated and run as 
native proteins on a 30×1.5-cm Sephacryl S-200 gel filtration column or denatured into 
polypeptides and separated on SDS-PAGE. In the gel filtration experiment, the eluted 
proteins were quantitated by measuring the absorbance at 280 nm. Figure 5.4A shows the 
absorbance profiles of the intermembrane space proteins released by hypotonic shock and 
1:10 ceramide:mitochondrial protein (w/w) (samples from vehicle-treated mitochondria 
were subtracted from both traces) as a function of molecular weight. Figure 5.4B presents 
the proteins released by ceramide as a percentage of the proteins released by the 
hypotonic shock. A cutoff of around 135 kDa is observed from these profiles.  
 The SDS-PAGE analyzed protein fractions (figure 5.4C) show a smaller cutoff. 
With increasing concentrations, the ceramide is able to release more proteins until it 
approaches the total amount of protein present (as in shocked). Vehicle controls were 
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used and subtracted as background. In figure 5.4D, the intensity of the released proteins 
from the gel is plotted against the molecular weight of each band. There is a clear cutoff 
of about 115 kDa. This is inconsistent with the cutoff measurement by our lab (Siskind et 
al., 2002), however, the delivery method of ceramide is different (more efficient with 
isopropanol as a solvent). The two methods agree that the size of the ceramide channel in 
mitochondria within 10 minutes of incubation is sufficient to release large molecular 
weight intermembrane space proteins. This corresponds to a diameter of around 6.5 nm 
(Eq. 3). This is on the lower side of the sizes measured in electrophysiology or TEM 
experiments.  However, since mitochondrial membranes have various proteins and/or 
lipids that may have an impact on channel formation and growth, this result does not 
seem too surprising. The possibility that mitochondria can regulate the ceramide channel 
size may be important in the regulation of the starting phase of apoptosis. If, for instance, 
the factors that limit the enlargement of the channel are active, ceramide might not be 
able to release intermembrane space proteins, even though the concentration of ceramide 
is sufficient. On the other hand, if those factors are inactivated the channel may grow and 






FIG. 5.4. Ceramide forms channels in mitochondria with a cutoff of between 115 and 135
kDa. (A) Gel filtration size-exclusion chromatography of released proteins shows a cutoff size 
of around 135 kDa. Intermembrane space proteins released by hypotonic shock and by 1:10 
C16-ceramide:mitochondrial protein (w/w) are detected as they come out of the column by an 
absorbance monitor. The background, isopropanol treated mitochondrial trace was subtracted 
from each. The ceramide-treated mitochondria show a scale-down version of the total protein 
release, however, there is a clear lack of release by ceramide beyond the 135 kDa point. The 
void volume of the column corresponded with Mr of 215 kDa. (B) The ceramide trace is 
plotted as the percentage of the shocked. The cutoff is evident at 135 kDa. (C) An SDS-
PAGE gel of intermembrane space proteins released by 2. hypotonic shock, 3. 1:10, 4. 1:30, 
and 5. vehicle treatment. Lane 1. shows the standards with the corresponding Mr in kDa. (D) 
A densitometry plot showing the percent protein released by the 2 doses of ceramide (lanes 3 
and 4) compared to the total proteins (lane 2). The background (lane 5) was subtracted. 
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 Of the various pathways proposed to release proteins from mitochondria to 
initiate the execution phase of apoptosis (Crompton et al., 1998; Basañez et al., 1999; 
Pastorino et al., 1999; Antonsson et al., 2000; Belaud-Rotureau et al., 2000; Saito et al., 
2000; Antonsson et al., 2001; Pavlov et al., 2001; Kuwana et al., 2001), only the 
ceramide channel is now well characterized.  There is a proposed structure that has been 
shown to be stable by molecular dynamics simulation (Anishkin et al., 2006).  Here we 
present direct visualization of the channels.  Ceramide levels increase in mitochondria 
early in apoptosis (Garcia-Ruiz et al., 1997; Matsko et al., 2001; Dai et al., 2004; Birbes 
et al., 2005) to levels sufficient to generate ceramide channels (Siskind et al., 2006).  
Thus a strong case can now be made for ceramide channels being the pathway for 
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CHAPTER 6  
FUTURE DIRECTIONS 
  
 In this dissertation, I presented my work on ceramide, its metabolism, its transport 
and its channel-formation ability. Ceramide is a very interesting lipid to study because of 
its unusual characteristics and its importance for the life and death of the cell. Future 
studies on this subject are currently under way, so in this chapter I will illustrate feasible 
directions to study the ceramide phenomenon.  
 
Membrane-specificity of ceramide channel formation 
  
 As was previously mentioned, ceramide can form channels in planar phospholipid 
bilayers, synthetic lipid vesicles and mitochondrial outer membranes. Moreover, 
ceramide cannot permeabilize the inner membrane of mitochondria, nor does it form 
channels in the plasma membrane. This raises the question of membrane specificity. The 
lipid environment could be very crucial in allowing ceramide molecules to form 
energetically favorable channels.  
 A future work regarding the lipid specificity should be investigated using 
different lipid compositions to test channel formation activity in carboxyfluorescein-
DPX-filled liposomes. This work may help illustrate the requirement of certain lipids 
over others to favor channel formation. This could lead to further mechanistic studies 





ER permeabilization by ceramide 
 Since the ceramide is almost exclusively made in the endoplasmic reticulum, it is 
important to see whether it can form channels there. Certainly, this goal coincides with 
the pervious one of testing the lipid dependence of channel formation. Nevertheless, the 
complexity of the ER system and the variety of proteins and factors available on that 
membrane may influence the results of pure lipid dependence experiments. 
 Isolated microsomes can be assessed for their intactness (in other words, 
permeability) using a substance called 4-methylumbelliferryl α-glucoside (4MαG) taking 
advantage of the ER enzyme α-glucosidase (Heritage and Wonderlin, 2001). The 
accessibility of this substance to the enzyme will lead to an increase in the fluorescence 
of the product, 4-methylumbelliferrone.  Hence, the permeability of the ER membranes 
can be proportional to the rate of hydrolysis of 4MαG. 
 A dose dependence, as well as time dependence, of exogenously-added ceramide 
permeabilization of ER membranes can be done to see if ceramide is able to form 
channels in the membrane in which it is synthesized. Provided that ceramide can form 
channels in the ER, a protein analysis of the released ER proteins should follow. Another 
experiment one could think of is to see whether the endogenously-made ceramide (by the 
de novo synthesis, using dihydroceramide and NAD(P)H as substrates) can also 
permeabilize the ER.   
 
Ceramide and VDAC collaboration? 
 The main mitochondrial outer membrane channel is the Voltage-Dependent 
Anion Channel, VDAC. The role of VDAC in the programmed cell death still remains 
controversial. VDAC is too small to allow proapoptotic proteins to pass to initiate 
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apoptosis. There are some indications that VDAC may be a part of the permeability 
transition pore complex, PTPC (Szabo and Zoratti, 1993; Szabo et al., 1993; Crompton et 
al., 1998; Marzo et al., 1998). Other results rule out the presence of VDAC in PTPC 
(Halestrap et al., 2002). However, more convincing experiments show that the closure of 
VDAC is important to initiate the cytochrome c dependent apoptotic pathway (Doran and 
Halestrap, 2000; Vander Heiden et al., 2000). Can the closure of VDAC and the elevation 
of ceramide levels in mitochondria be integrated? Does the closure of VDAC allow the 
recruitment of ceramide to the mitochondria? Ceramide was shown to permeabilize yeast 
mitochondria lacking VDAC1, but is there a common ground between these two, very 
different, outer membrane channels? 
  
Interaction between ceramide and Bcl-2 family proteins 
 Ceramide’s interaction with Bcl-2 family proteins, whether anti-apoptotic (for 
instance Bcl-xL and Bcl-2) or pro-apoptotic (e.g. Bax) is currently being studied. Our lab 
has shown that Bcl-2 and Bcl-xL are able to disassemble ceramide channels in planar 
phospholipid membranes. More mechanistic experiments designed to see if there is actual 
binding of ceramide to these proteins should be done in order to specifically deduce that 
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